Publikationen

Veröffentlichungen allgemein

1.      Turski CA, Turski GN, Faber J, Teipel SJ, Holz FG, Klockgether T, Finger RP. Microvascular Breakdown Due to Retinal neurodegeneration in Ataxias. Mov Disord, 2021, online ahead of print (IF 10,34)

2.      Wang C, Wang Z, Xie B, Shi X, Yang P, Liu L, Qu T, Qin Q, Xing Y, Zhu W, Teipel SJ, Jia J, Zhao G, Li L, Tang Y. Binaural processing deficit and cognitive impairment in AD. Alzheimers Dement, 2021, online ahead of print (IF 21,57)

3.      Lemercier P, Vergallo A, Lista S, Zetterberg H, Blennow K, Potier MC, Habert MO, Lejeune FX, Dubois B, Teipel SJ, Hampel H; INSIGHT-preAD study group and the Alzheimer Precision Medicine Initiative (APMI). Association of plasma Aß40/Aß42 ratio and brain Aß accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer:s disease. Neurobiol Aging, 2021, 107:57-69 (IF 4,67)

4.      Teipel S, Bruno D, Plaska CR, Heslegrave A, Ramos-Cejudo J, Osorio RS, Zetterberg H, Blennow K, Pomara N. Association of CSF STREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder. J Affect Disord, 2021, 24;293:429-434 (IF 4,84)

5.      Teipel SJ, Brüggen K, Temp AGM, Jakobi K, Weber MA, Berger C. Simultaneous Assessment of Electroencephalography Microstates and Resting State Intrinsic Networks in Alzheimer’s Disease and healthy Aging. Front Neurol., 2021, 17;12:637542 (IF 3,55)

6.      Kowe A, Köhler S, Teipel S. Improving the depth of data quality or increasing confusion? Reflections on a data analysis involving members of a selfhelp group for relatives of people living with dementia. Health Expect., 2021, Epub ahead of print (IF 3,38)

7.      Scherr M, Utz L, Tahmasian M, Pasquini L, Grothe MJ, Rauschecker JP, Grimmer T, Drzezga A, Sorg C, Riedl V. Effective connectivity in the default mode network is distinctively disrupted in AD – A simultaneous resting-state FDG-PET/fMRI study. Hum Brain Mapp, 2021, 42(13):4134-4143 (IF 5,04)

8.      Aghourian M, Aumont E, Grothe MJ, Soucy JP, Rosa-Neto P, Bedard MA. FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry. J Neuroimaging, 2021, online ahead of print (IF 6,56)

9.      Berlot R, Pirtosek Z, Brezovar S, Koritnik B, Teipel SJ, Grothe MJ, Ray NJ. Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson’s disease. Brain Imaging Behav., 2021, Epub ahead of print (IF 3,98)

10.    Hedderich DM, Menegaux A, LiH, Schmitz-Koep B, Stämpfli P, Bäuml JG, Berndt MT, Bäuerlein FJB, Grothe MJ, Dyrba M, Avram M, Boecker H, Daamen M, Zimmer C, Bartmann P, Wolke D, Sorg C. Aberrant Claustrum Micorstructure in Humans after Premature Birth. Cereb Cortex, 2021, Epub ahead of print (IF 5,38)

11.    Klein OA, Boekholt M, Afrin D, Dornquast C, Dreier-Wolfgramm  A, Keller A, Michalowsky B, Zwingmann I, Teipel S, Thyrian JR, Kilimann I, Hoffmann W. Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a clustr randomised controlled trial (GAIN). Trials, 2021. 22(1):401 (IF 2,28)

12.    Klein OA, Boekholt M, Afrin D, Dornquast C, Dreier-Wolfgramm  A, Keller A, Michalowsky B, Zwingmann I, Teipel S, Thyrian JR, Kilimann I, Hoffmann W. Correction to: Effectiveness of a digitally supported care management programme to reduce unmet needs of family caregivers of people with dementia: study protocol for a clustr randomised controlled trial (GAIN). Trials, 2021. 22(1):432 (IF 2,28)

13.    Temp AGM, Dyrba M, Kasper E, Teipel S, Prudlo J. Case Report: Cognitive Conversion in a Non-brazilian VAPB Mutation Carrier (ALS8). Front Neurol., 2021, 12:668772 (IF 3,55)

14.    Temp AGM, Dyrba M, Büttner C, Kasper E, Machts J, Kaufmann J, Vielhaber S, Teipel S, Prudlo J. Cognitive Profiles of Amyotrophic Lateral Sclerosis Differ in Resting-State Functional Connectivity: An fMRI-Study. Front Neurosci, 2021, 15:682100 (IF 4,68)

15.    Rauchmann BS, Ersoezlue E, Stoecklein S, Keeser D, Brosseron F, Buerger K, Dechent P, Dobisch L, Ertl-Wagner B, Fliessbach K, Haynes JD, Heneka MT, Incesoy EI, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Ramirez A, Roeske S, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Vukovich R, Wagner M, Wiltfang J, Yakupov R, Duezel E, Jessen F, Perneczky R; DELCODE study group and the Alzheimer's Disease Neuroimaging Initiative (ADNI). Resting-State Network Alterations Differ between Alzheimer's Disease Atrophy Subtypes. Cereb Cortex. 2021 Jun 3, doi: 10.1093/cercor/bhab130. Epub ahead of print (IF 5,04)

16.    Temp AGM, Lutz MW, Trepel D, Tang Y, Wagenmakers EJ, Khachaturian AS, Teipel S. How Bayesian statistics may help answer some of the controversial questions in clinical research on Alzheimer's disease. Alzheimers Dement. 2021 Jun;17(6):917-919. doi: 10.1002/alz.12374. (IF 21,57)

17.    Groot C, Grothe MJ, Mukherjee S, Jelistratova I, Jansen I, van Loenhoud AC, Risacher SL, Saykin AJ, Mac Donald CL, Mez J, Trittschuh EH, Gryglewski G, Lanzenberger R, Pijnenburg YAL, Barkhof F, Scheltens P, van der Flier WM, Crane PK, Ossenkoppele R. Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups. Neuroimage Clin. 2021 Apr 3;30:102660. doi: 10.1016/j.nicl.2021.102660. Epub ahead of print (IF )

18.    Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter MA, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, Nordberg A, Ossenkoppele R, Villemagne VL, Winblad B, Frisoni GB, Garibotto V. Correction to: The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. Eur J Nucl Med Mol Imaging. 2021, 48(7):2070-2085 (IF 7,08).

19.    Boccardi M, Dodich A, Albanese E, Gayet-Ageron A, Festari C, Ashton NJ, Bischof GN, Chiotis K, Leuzy A, Wolters EE, Walter MA, Rabinovici GD, Carrillo M, Drzezga A, Hansson O, Nordberg A, Ossenkoppele R, Villemagne VL, Winblad B, Frisoni GB, Garibotto V. The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update. Eur J Nucl Med Mol Imaging. 2021, online ahead of print (IF 7,08).

20.    Garibotto V, Boccardi M, Chiti A, Frisoni GB. Molecular imaging and fluid biomarkers of Alzheimer's disease neuropathology: an opportunity for integrated diagnostics. Eur J Nucl Med Mol Imaging. 2021, 48(7): 2067-2069 (IF 7,08)

21.  Cotta Ramusino M, Perini G, Altomare D, Barbarino P, Weidner W, Salvini Porro G, Barkhof F, Rabinovici GD, van der Flier WM, Frisoni GB, Garibotto V, Teipel S, Boccardi M. Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2157-2168 (IF 7,08)

22.  Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O. 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139.  (IF 7,08)

23.    Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2140-2156.  (IF 7,08)

24.    Boccardi M, Monsch AU, Ferrari C, Altomare D, Berres M, Bos I, Buchmann A, Cerami C, Didic M, Festari C, Nicolosi V, Sacco L, Aerts L, Albanese E, Annoni JM, Ballhausen N, Chicherio C, Démonet JF, Descloux V, Diener S, Ferreira D, Georges J, Gietl A, Girtler N, Kilimann I, Klöppel S, Kustyniuk N, Mecocci P, Mella N, Pigliautile M, Seeher K, Shirk SD, Toraldo A, Brioschi-Guevara A, Chan KCG, Crane PK, Dodich A, Grazia A, Kochan NA, de Oliveira FF, Nobili F, Kukull W, Peters O, Ramakers I, Sachdev PS, Teipel S, Visser PJ, Wagner M, Weintraub S, Westman E, Froelich L, Brodaty H, Dubois B, Cappa SF, Salmon D, Winblad B, Frisoni GB, Kliegel M; Consortium for the Harmonization of Neuropsychological Assessment for Neurocognitive Disorders. Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe. Alzheimers Dement., 2021, Epub ahead of print (IF 21,57)

25.    Müller B, Kropp P, Cardona MI, Michalowsky B, van den Berg N, Teipel S, Hoffmann W, Thyrian JR. Types of leisure time physical activities (LTPA) of community-dwelling persons who have been screened positive for dementia. BMC Geriatr., 2021, 21(1):270 (IF 3,82)

26.    Hansen N, Singh A, Bartels C, Brosseron F, Buerger K, Cetindag AC, Dobisch L, Dechent P, Ertl-Wagner BB, Fliessbach K, Haynes JD, Heneka MT, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Vukovich R, Wiltfang J, Duezel E, Jessen F, Goya-Maldonado R. Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline. Front Aging Neurosci., 2021,  13:626974 (IF 4,36)

27.    Ballarini T, Melo van Lent D, Brunner J, Schröder A, Wolfsgruber S, Altenstein S, Brosseron F, Buerger K, Dechent P, Dobisch L, Düzel E, Ertl-Wagner B, Fliessbach K, Freiesleben SD, Frommann I, Glanz W, Hauser D, Haynes JD, Heneka MT, Janowitz D, Kilimann I, Laske C, Maier F, Metzger CD, Munk M, Perneczky R, Peters O, Priller J, Ramirez A, Rauchmann B, Roy N, Scheffler K, Schneider A, Spottke A, Spruth EJ, Teipel SJ, Vukovich R, Wiltfang J, Jessen F, Wagner M; DELCODE study group. Mediterranean Diet, Alzheimer Disease Biomarkers and Brain Atrophy in Old Age. Neurology., 2021, Epub ahead of print (IF 8,77)

28.    Babiloni C, Arakaki X, Bonanni L, Bujan A, Carrillo MC, Del Percio C, Edelmayer RM, Egan G, Elahh FM, Evans A, Ferri R, Frisoni GB, Güntekin B, Hainsworth A, Hampel H, Jelic V, Jeong J, Kim DK, Kramberger M, Kumar S, Lizio R, Nobili F, Noce G, Puce A, Ritter P, Smit DJA, Soricelli A, Teipel S, Tucci F, Sachdev P, Valdes-Sosa M, Valdes-Sosa P, Vergallo A, Yener G. EEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel. Neurobiol Aging, 2021, 103:78-97, Epub ahead of print (IF 4,35)

29.    Babiloni C, Arakaki X, Azami H, Bennys K, Blinowska K, Bonanni L, Bujan A, Carrillo MC, Cichocki A, de Frutos-Lucas J, Del Percio C, Dubois B, Edelmayer R, Egan G, Epelbaum S, Escudero J, Evans A, Farina F, Fargo K, Fernández A, Ferri R, Frisoni G, Hampel H, Harrington MG, Jelic V, Jeong J, Jiang Y, Kaminski M, Kavcic V, Kilborn K, Kumar S, Lam A, Lim L, Lizio R, Lopez D, Lopez S, Lucey B, Maestú F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Noce G, Olichney J, Onofrj M, Osorio R, Parra-Rodriguez M, Rajji T, Ritter P, Soricelli A, Stocchi F, Tarnanas I, Taylor JP, Teipel S, Tucci F, Valdes-Sosa M, Valdes-Sosa P, Weiergräber M, Yener G, Guntekin B. Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel. Alzheimers Dement. 2021 Apr 15. doi: 10.1002/alz.12311. Epub ahead of print (IF 17,13)

30.    Temp AGM, Prudlo J, Vielhaber S, Machts J, Hermann A, Teipel SJ, Kasper E. Cognitive reserve and regional brain volume in amyotrophic lateral sclerosis. Cortex. 2021 Jun;139:240-248. doi: 10.1016/j.cortex.2021.03.005. Epub 2021 Mar 17 (IF 4,58)

31.    Müller L, Kirschstein T, Köhling R, Kuhla A, Teipel S. Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease. J Alzheimers Dis., 2021, doi: 10.3233/JAD-201540. Epub ahead of print. (IF 3,91)

32.    Faraza S, Waldenmaier J,  Dyrba M, Wolf D, Fischer FU, Knaepen K, Kollmann B, Tüscher O, Binder H, Mierau A, Riedel D, Fellgiebel A, Teipel S. Dorsolateral Prefrontal Functional Connectivity Predicts Working Memory Training Gains. Front Aging Neurosci , 2021, 1;13:592261. doi: 10.3389/fnagi.2021.592261. PMID: 33732134; (IF 4,36)

33.    Vergallo A, Lista S, Zhao Y, Lemercier P, Teipel SJ, Potier MC, Habert MO, Dubois B, Lukiw WJ, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl Psychiatry., 2021, 11(1):78 (IF 5,90)

34.    Müller L, Power Guerra N, Stenzel J, Rühlmann C, Lindner T, Krause BJ, Vollmar B, Teipel S, Kuhla A. Long-Term Caloric Restriction Attenuates β-Amyloid Neuropathology and Is Accompanied by Autophagy in APPswe/PS1delta9 Mice. Nutrients, 2021, 13(3):985 (IF 4,55)

35.    Müller P, Vellage AK, Schmicker M, Menze I, Grothe MJ, Teipel SJ, Müller NG. Structural MRI of the basal forebrain as predictor of cognitive response to galantamine in healthy older adults-A randomized controlled double-blinded crossover study. Alzheimers Dement (N Y), 2021, 7(1):e12153

36.    Lüdtke S, Hermann W, Kirste T, Benes H, Teipel SJ. An Algorithm for actigraphy-based sleep/wake scoring: Comparison with polysomnography. Clin Neurophysiol., 2021, 132(1):137-145 (IF 3,21)

37.    Wesselman LMP, van Lent DM, Schröder A, van de Rest O, Peters O, Menne F, Fuentes M, Priller J, Spruth EJ, Altenstein S, Schneider A, Fließbach K, Roeske S, Wolfsgruber S, Kleineidam L, Spottke A, Pross V, Wiltfang J, Vukovich R, Schild AK, Düzel E, Metzger CD, Glanz W, Buerger K, Janowitz D, Perneczky R, Tato M, Teipel SJ, Kilimann I, Laske C, Buchmann M, Ramirez A, Sikkes SAM, Jessen F, van der Flier WM, Wagner M. Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk für Alzheimer’s disease. Eur J Nutr., 2021, 60(2):849-860 (IF 4,45)

38.    Altomare D, Caprioglio C, Assa F, Allali G, Mendes A, Ribaldi F, Ceyzeriat K, Martins M, Tomczyk S, Stampacchia S, Dodich A, Boccardi M, Chicherio C, Frisoni GB, Garibotto V. Diagnostic value of amyloid-PET and tau-PET: a head-tohead comparison. Eur J Nucl Med Mol Imaging, 2021, 48(7): 2200-2211 (IF 7,08)

39.    Bischof GN, Dodich A, Boccardi M, van Eimeren T, Festari C, Barthel H, Hansson O, Nordberg A, Ossenkoppele R, Sabri O, Giovanni BFG, Garibotto V, Drzezga A. Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework. Eur J Nucl Med Mol Imaging, 2021, 48(7): 2110-2120 (IF 7,08)

40.    Chiotis K, Dodich A, Boccardi M, Festari CJ, Drzezga A, Hansson O, , Ossenkoppele R, Frisoni GB, Garibotto V, Nordberg A. Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework. 2021, Eur J Nucl Med Mol Imaging, 2021, 48(7): 2086-2096 (IF 7,08)

41.    Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodriguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM McDade E, Buerger K, Levin J, Duering M, Dichgans M, Suárez-Calvet M, Haass C, Gordon BA, Lim YY, Masters CL, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Milz E, Moreno-Grau S, Teipel SJ, Grothe MJ, Kilimann I, Rossor M, Fox N, Laske C, Chhatwal J, Falkai P, Perneczky R, Lee JH, Spottke A, Boecker H, Brosseron F, Fliessbach K, Heneka MT, Nestor P, Peters O, Fuentes M, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÁ, Metzger C, Bittner D, Salloway S, Danek A, Hassenstab J, Yakushev I, Schofield PR, Morris JC, Bateman RJ, Ewers M. The BDNF Val66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease. Mol Psychiatry, 2021, 26(2):614-628 (IF 11,97)

42.    Amaefule CO, Dyrba M, Wolfsgruber S, Polcher A, Schneider A, Fliessbach K, Spottke A, Meiberth D, Preis L, Peters O, Incesoy EI, Spruth EJ, Priller J, Altenstein S, Bartels C, Wiltfang J, Janowitz D, Bürger K, Laske C, Munk M, Rudolph J, Glanz W, Dobisch L, Haynes JD, Dechent P, Ertl-Wagner B, Scheffler K, Kilimann I, Düzel E, Metzger CD, Wagner M, Jessen F, Teipel SJ. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer’s disease spectrum. Neuroimage Clin, 2021, 29:102533, online ahead of print (IF 4,35)

43.    Teipel SJ, Temp AGM, Levin F, Dyrba M, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum. J Alzheimers Dis. 2021;79(2):663-670. (IF 3,91)

44.    Li S, Daamen M, Scheef L, Gaertner FC, Buchert R, Buchmann M, Buerger K, Catak C, Dobisch L, Drzezga A, Ertl-Wagner B, Essler M, Fliessbach K, Haynes JD, Incesoy EI, Kilimann I, Krause BJ, Lange C, Laske C, Priller J, Ramirez A, Reimold M, Rominger A, Roy N, Scheffler K, Maurer A, Schneider A, Spottke A, Spruth EJ, Teipel SJ, Tscheuschler M, Wagner M, Wolfsgruber S, Düzel E, Jessen F, Peters O, Boecker H; DELCODE Study Group. Abnormal Regional and Global Connectivity Measures in Subjective Cognitive Decline Depending on Cerebral Amyloid Status. J Alzheimers Dis. 2021;79(2):493-509 (IF 3,91)

45.    Levin F, Ferreira D, Lange C, Dyrba M, Westman E, Buchert R, Teipel SJ, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration. Alzheimers Res Ther. 2021 Feb 19;13(1):49 (IF 6,12)

46.    Vergallo A, Lista S, Zhao Y, Lemercier P, Teipel SJ, Potier MC, Habert MO, Dubois B, Lukiw WJ, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints. Transl Psychiatry. 2021 Jan 27;11(1):78. doi: 10.1038/s41398-020-01184-8 (IF 5,28)

47.    Vergallo A, Lemercier P, Cavedo E, Lista S, Vanmechelen E, De Vos A, Zetterberg H, Blennow K, Habert MO, Potier MC, Dubois B, Teipel SJ, Hampel H; INSIGHT-preAD study group, and the Alzheimer Precision Medicine Initiative (APMI). Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD. Alzheimers Dement. 2021 Feb 1. doi: 10.1002/alz.12228. Epub ahead of print. (IF 21,57)

48.    Görß D, Kilimann I, Dyrba M, Nitsch S, Krause B, Teipel SJ. [LATE: not every dementia is Alzheimer’s disease-Discussion of a new disease entity based on a case example: Current status of limbic-predominant age-related TDP-43encephalopathy (LATE)]. Nervenarzt, 2021, 92(1):18-26 (IF 0,83)

49.    Gonzalez-Escamilla G, Miederer I, Grothe MJ, et al. Metabolic and amyloid PET network reorganization in Alzheimer's disease: differential patterns and partial volume effects. Brain Imaging Behav., 2021, 15(1):190-204 (IF 3,42)

1.     Kowe A, Köhler S, Klein OA, Lüthje C, Kalzendorf J, Weschke S, Teipel SJ. Stakeholder involvement in dementia research: A qualitative approach with healthy senior citizens and providers of dementia in Germany. Health Soc Care Community, 2020, online ahead of print (IF 2,05)

2.     Herdick M, Dyrba M, Fritz HJ, Altenstein S, Ballarini T, Brosseron F, Buerger K, Can Cetindag A, De-chent P, Dobisch L, Duezel E, Ertl-Wagner B, Fliessbach K, Dawn Freiesleben S, Frommann I, Glanz W, Dylan Haynes J, Heneka MT, Janowitz D, Kilimann I, Laske C, Metzger CD, Munk MH, Peters O, Priller J, Roy N, Scheffler K, Schneider A, Spottke A, Jakob Spruth E, Tscheuschler M, Vukovich R, Wiltfang J, Jessen F, Teipel SJ, Grothe MJ. Multimodal MRI analysis of basal forebrain structure and function across the Alzheimer's disease spectrum. Neuroimage Clin. 2020, 28:102495 (IF 4,35)

3.     Teipel SJ, Temp AGM, Levin F, Dyrba M,Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Associaton of PET-based stages of amyloid deposition with neuropathological markers of Aß- pathology. Ann Clin Transl. Neurol., 2020,  8(1):29-42 (IF 3,66)

4.     Fuentes M, Klostermann A, Kleineidam L, Bauer C, Schuchardt J, Maier W, Jessen F, Fröhlich L, Wiltfang J, Kornhuber J, Klöppel S, Schieting V, Teipel SJ, Wagner M, Peters O. Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer’s Disease Dementia via Lead-Lag Analysis. J Alzheimers Dis, 2020, 76(3):1005-1015 (IF 3,91)

5.     Wolf D, Fischer FU, Riedel D, Knaepen K, Kollmann B, Kocabayoglu M, Brüggen K, Teipel SJ, Tüscher O, Binder H, Mierau A, Fellgiebel A. The Impact of Age on the Association between Physical Activity and White Matter Integrity in Cognitively Healthy Older Adults. Front Aging Neurosci., 2020, 5;12:579470 (IF 4,50)

6.     Amaefule CO, Lüdtke S, Kirste T, Teipel SJ. Effect of Spatial Disorientation in a virtual environment on gait and vital features in patients with dementia: Pilot Single-Blind Randomized Control Trial. JMIR Serious Games, 2020, 8(4):e18455 (IF 3,53)

7.     Sannemann L, Schild AK, Altenstein S, Bartels C, Brosseron F, Buerger K, Cosma NC, Fliessbach K, Freiesleben SD, Glanz W, Heneka MT, Janowitz D, Kilimann I, Kobeleva X, Laske C, Metzger CD, Munk MHJ, Perneczky R, Peters O, Polcher A, Priller J, Rauchmann B, Rösch C, Rudolph J, Schneider A, Spottke A, Spruth EJ, Teipel SJ, Vukovich R, Wagner M, Wiltfang J, Wolfsgruber S, Duezel E, Jessen F; DELCODE Study Group. Neuropsychiatric symptoms in at-risk groups for AD dementia and their association with worry and AD biomarkers-results from the DELCODE study. Alzheimers Res Ther., 2020, 12(1):131 (IF 6,11)

8.     Kuhla A, Meuth L, Stenzel J, Lindner T, Lappe C, Kurth J, Krause BJ, Teipel SJ, Glass Ä, Kundt G, Vollmar B. Longitudinal [18F]FDG-PET/CT analysis of the glucose metabolism in ApoE-deficient mice. EJNMMI Res., 2020, 10(1):119 (IF 2,64)

9.     Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fernàndez A, Frisoni G, Guntekin B, Hajos M, Hampel H, Ifeachor E, Kilborn K, Kumar S, Johnsen K, Johannsson M, Jeong J, Le Beau F, Lizio R, Lopes da Silva F, Maestú F, Mc Geown WJ, Mc Keith I, Moretti DV, Nobili F, Olichney J, Onofrj M, Palop JJ, Rowan M, Stocchi F, Struzik ZM, Tanila H, Teipel SJ, Taylor JP, Weiergräber M, Yener G, Young-Pearse T, Drinkenburg WH, Randall F. What electrophysiology tells us about Alzheimer’s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging, 2020, 85:58-73 (IF 4,40)

10.  Cavedo E, Lista S, Houot M, Vergallo A, Grothe MJ, Teipel SJ, Zetterberg H, Blennow K, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group and the Alzheimer Predicion Medicine. Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease. Neurology, 2020, 94(1) (IF 7,35)

11.  Schaat S, Koldrack P, Yordanova K, Kirste T, Teipel SJ. Real-Time Detection of Spatial Disorientation in Persons with Mild Cognitive Impairment and Dementia. Gerontology, 2020, 66(1): 85-94 (IF 3,35)

12.  Finsterwalder S, Vlegels N, Gesierich B, Araque Caballero MÁ, Weaver NA, Franzmeier N, Georgakis MK, Konieczny MJ, Koek HL; Dominantly Inherited Network (DIAN), Karch CM, Graff-Radford NR, Salloway S, Oh H, Allegri RF, Chhatwal JP; DELCODE study group, Jessen F, Düzel E,Dobisch L, Metzger O, Incesoy EI, Priller J, Spruth EJ, Schneider A, Fließbach K, Buerger K, Janowitz D, Teipel SJ, Kilimann I, Laske C, Buchmann M, Heneka MT, Brosseron FA, Roy N, Ertl-Wagner B, Scheffler K; Alzheimer’s Disease Neuroimaging Initiative (ADNI); Utrecht VCI study group, Seo SW, Kim Y, Na DL, Kim HJ, Jang M, Levin J, Schmidt R, Pasternak O, Dichgans M, Biessels GJ, Duering M. Small vessel disease more than Alzheimer’s disease determines diffusion MRI alterations in memory clinic patients. Alzheimers Dement, 2020, 16(11):1504-1514 (IF 17,13)

13.  Babiloni C, Lopez S, Del Percio C, Noce G, Pascarelli MT, Lizio R, Teipel SJ, González-Escamilla G, Bakardjian H, George N, Cavedo E, Lista S, Chiesa PA, Vergallo A, Lemercier P, Spinelli G, Grothe MJ, Potier MC, Stocchi F, Ferri R, Habert MO, Fraga FJ, Dubois B, Hampel H; INSIGHT-preAD Study Group. Resting-state posterior alpha rhythms are abnormal in subjective memory complaint seniors with preclinical Alzheimer’s neurophathology and high education level: the INSIGHT-preAD study. Neurobiol Aging, 2020, 90:43-59 (IF 4,40)

14.  Nemy M, Cedres N, Grothe MJ, Muehlboeck JS, Lindberg O, Nedelska Z, Stepankova O, Vyslouzilova L, Eriksdotter M, Barroso J, Teipel SJ, Westman E, Ferreira D. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. Neuroimage, 2020, 211:116607 (IF 5,81)

15.  Zwingmann I, Dreier-Wolfgramm A, Esser A, Wucherer D, Thyrian JR, Eichler T, Kaczynski A, Monsees J, Keller A, Hertel J, Kilimann I, Teipel SJ, Michalowsky B, Hoffmann W. Why do family dementia caregivers reject caregiver support services) Analyzing types of rejection and associated health-impairments in a cluster-randomized controlled intervention trial. BMC Health Serv Res, 2020, 20(1):121 (IF 2,64)

16.  Wolfsgruber S, Kleineidam L, Guski J, Polcher A, Frommann I, Roeske S, Spruth EJ, Franke C, Priller J, Kilimann I, Teipel SJ, Buerg K, Janowitz D, Laske Buchmann M, Peters O, Menne F, Fuentes Casan M, Wiltfang J, Bartels C, Düzel E, Metzger C, Glanz W, Thelen M, Spottke A, Ramirez A, Kofler B, Fließbach K, Schneider A, Heneka MT, Brosseron F, Meiberth D, Jessen F, Wagner M; DELCODE Study Group. Minor neuropsychological deficits in patients with subjective cognitive decline. Neurology, 2020, 95(9):e1134-e1143 (IF 7,35)

17.  Kalzendorf j, Brueggen K, Teipel SJ. Cognitive Reserve is not associated with hippocampal microstructure in older adults without dementia. Front Aging Neurosci, 2020, 11:380 (IF 4,50)

18.  Jelistratova I, Teipel SJ, Grothe MJ. Longitudinal validity of PET-based staging of regional amyloid deposition. Hum Brain Mapp, 2020, 41(15):4219-31 (IF 4,42)

19.  Teipel SJ, Fritz HC, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Neuropathological features associated with basal forebrain atrophy in Alzheimer disease. Neurology, 2020, 95(10):e1301-e1311 (IF 7,35)

20.  Goerss D, Hein A, Bader S, Halek M, Kernebeck S, Kutschke A, Heine C, Krueger F, Kirste T, Teipel SJ. Automated sensor-based detection of challenging behaviors in advanced stages of dementia in nursing homes. Alzheimers Dement, 2020, 16(4):672-680 (IF 17,13)

21.  Teipel SJ, Dyrba M, Chiesa PA, Sakr F, Jelistratova I, Lista S, Vergallo A, Lemercier P, Cavedo E, Habert MO, Dubois B, Hampel H, Grothe MJ; INSIGHT-preAD study group and for the Alzheimer’s Disease Neuroimaging Initiative. In vivo staging of regional amyloid deposition predicts functional conversion in the preclinical and prodromal phases of Alzheimer’s disease. Neurobiol Aging, 2020, 93:98-108 (IF 4,40)

22.  Wittstock M, Wilde N, Grossmann A, Kasper E, Teipel SJ. Mirror movements in Amyotrophic Lateral Sclerosis: a combined study using diffusion tensor imaging and transcranial magnetic stimulation. Front Neurol., 2020, 11:164 (IF 2,64)

23.  Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger A, Teipel SJ, Wahlberg LU, Wahlund LO, Westmann E, EriksdotterM; Alzheimer’s Disease Neuroimaging Initiative. The cholinergic system in subtypes of Alzheimer’s disease: an in vivo longitudinal MRI study. Alzheimers Res Ther., 2020, 12(1):51 (IF 7,07)

24.  Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A,, Shah-Hosseini K, Teipel SJ, von Arnim CAF, Wiltfang J, Jessen F. Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trail. JAMA Netw Open, 2020, 3(5):e206027 (IF -)

25.  Dyrba M, Mohammadi R, Grothe MJ, Kirste T, Teipel SJ. Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer’s Disease. Front Aging Neurosci., 2020, 12:99 (IF 3,63)

26.  Rhein C, Mühle C, Lenz B, Richter-Schmidinger T, Kogias G, Boix F, Lourdusamy A, Dörfler A, Peters O, Ramirez A, Jessen F, Maier W, Hüll M, Frölich L, Teipel SJ, Wiltfang J, Lornhuber J, Müller CP. Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly. Brain Res Bull., 2020, 161:13-20 (IF 3,10)

27.  Schulze F, Müller S, Guli X, Schumann L, Brehme H, Riffert T, Rohde M, Goerss D, Rackow S, Einsle A, Kirschstein T, Köhling R. CK2 Inhibition Prior to Status Epilepticus Persistently Enhances KCa2 Funtion in CA1 Which Slows Down Disease. Front Cell Neurosci., 2020, 14:33 (IF 3,90)

28.  Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C. Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods. Biol Psychiatry. 2020;88(1):70-82 (IF 6,49)

29.  Pereira JB, Hall S, Jalakas M, Grothe MJ, Strandberg O, Stomrud E, Westman E, van Westen D, Hansson O. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease. Neurobiol Dis. 2020;139:104831 (IF 5,16)

30.  Vogel JW, La Joie R, Grothe MJ, et al. A molecular gradient along the longitudinal axis of the human hippocampus informs large-scale behavioral systems. Nat Commun. 2020;11(1):960 (IF 11,88)

31.  Craig CE, Jenkinson NJ, Brittain JS, Grothe MJ, Rochester L, Silverdale M, Alho ATDL, Alho EJL, Holmes PS, Ray NJ. Pedunculopontine Nucleus Microstructure Predicts Postural and Gait Symptoms in Parkinson's Disease. Mov Disord, 2020, 25(7):119-1207 (IF 8,22)

32.  Hallab A, Lange C, Apostolova I, Özden C, Gonzalez-Escamilla G, Klutmann S, Brenner W, Grothe MJ, Buchert R; Alzheimer’s Disease Neuroimaging Initiative. Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex. J Alzheimers Dis., 2020, online ahead of print (IF 3,91)

33.  Özden C, Frings L, Apostolova I, Lange C, Klutmann S, Adam G, Bannas P, Meyer PT, Grothe MJ, Buchert R. FDG Uptake in the Basal Forebrain as Measured by Digital High-Resolution PET Is a Promising Marker of Basal Forebrain Degeneration in the Lewy Body Disease Spectrum: A Pilot Study. Clin Nucl Med. 2020;45(4):261-266 (IF 6,70)

1.     Teipel SJ, Kuper-Smith JO, Bartels C, Brosseron F, Buchmann M, Buerger K, Catak C, Janowitz D, Dechent P, Dobisch L, Ertl-Wagner B, Fließbach K, Haynes JD, Heneka MT, Kilimann I, Laske C, Li S, Menne F, Metzger CD, Priller J, Pross V, Ramirez A, Scheffler K, Schneider A, Spottke A, Spruth EJ, Wagner M, Wiltfang J, Wolfsgruber S, Düzel E, Jessen F, Dyrba M; DELCODE study group. Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer’s Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness. J Alzheimers Dis, 2019, e-pub ahead of print (IF 3,48)

2.     Toschi N, Lista S, Baldacci F, Cavedo E, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Habert MO, Dubois B, Floris R, Garaci F, Vergallo A, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Biomarker-guided clustering of Alzheimer’s disease clinical syndromes. Neurobiol Aging, 2019, e-pub ahead of print (IF 4,40)

3.     Berron D, Cardenas-Blanco A, Bittner D, Metzger CD, Spottke A, Heneka MT, Fliessbach K, Schneider A, Teipel SJ, Wagner M, Speck O, Jessen F, Düzel E. Higher CSF tau levels are related to hippocampal hyperactivity and object mnemonic discrimination on older adults. J Neurosci, 2019, epub ahead of print (IF 6,07)

4.     Brainbridge WA, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Dobisch L, Bittner D, Glanz W, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buch-mann M, Peters O,Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Schneider A, Kofler B, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Wolsgruber S, Wagner M, Jessen F, Baker CI, Düzel E. Memorability of photographs in subjective cognitive decline and mild cognitive impairment: Implications for cognitive assessment. Alzheimers Dement (Amst), 2019, 11:610-618 (IF 17,13)

5.     Michalowsky B, Xie F, Eichler T, Hertel J, Kaczynski A, Kilimann I, Teipel SJ, Wucherer D, Zwingmann I, Thyrian JR, Hoffmann W. Cost-effectiveness of a collaborative dementia care management-Results of a cluster-randomized controlled trial. Alzheimers Dement, 2019, e-pub ahead of print (IF 17,13)

6.     Miebach L, Wolfsgruber S, Polcher A, Peters O, Menne F, Luther K, Incesoy E, Priller J, Spruth E, Altenstein S, Buerger K, Catak C, Janowitz D, Perneczky R, Utecht J, Laske C, Buchmann M, Schneider A, Fliessbach K, Kalbhen P, Heneka MT, Brosseron F, Spottke A, Roy N, Teipel SJ, Kilimann I, Wiltfang J, Bartels C, Düzel E, Dobisch L, Metzger C, Meiberth D, Ramirez A, Jessen F, Wagner M. Which features of subjective cognitive decline are related to amyloid pathology? Finings from the DELCODE study. Alzheimers Res Ther., 2019, 11(1):66 (IF 7,07)

7.     Brueggen K, Dyrba M, Cardenas-Blanco A, Schneider A, Fliessbach K, Buerger K, Janowitz D, Peters O, Menne F Priller J, Spruth E, Wiltfang J, Vukovich R, Laske C, Buchmann M, Wagner M, Röske S, Spottke A, Rudolph J, Metzger CD, Kilimann I, Dobisch L, Düzel E, Jessen F, Teipel SJ; DELCODE Study Group. Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer’s disease based on multicenter diffusion tensor imaging. J Neurol, 2019, epub ahead of print (IF 4,20)

8.     Betts MJ, Cardenas-Blanco A, Kanowski M, Spottke A, Teipel SJ, Kilimann I, Jessen F, Düzel E. Locus coeruleus MRI contrast is reduced in Alzheimer’s disease dementia and correlates with CSF Aß levels. Alzheimers Dement, 2019, 11:281-285 (IF 17,13)

9.     Ramirez J, Górriz JM, Teipel S. Editorial: Multimodal and Longitudinal Bioimaging Methods for Characterizing the Progressive Course of Dementia. Front Aging Neurosci, 2019, 11:45 (IF 3,63)

10.  Tang Y, Xing Y, Zhu Z, He Y, Li F, Yang J, Liu Q, Li F, Teipel SJ, Zhao G, Jia J. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-Vaccine study): a randomized controlled trial. Alzheimers Dement, 2019, e-pub ahead of print (IF 17,13)

11.  Kernebeck S, Holle D, Pogscheba P, Jordan F, Mertl F, Huldtgren A, Bader S, Kirste T, Teipel SJ, Holle B, Halek M. A Tablet App- and Seonsor-Based Assistive Technology Intervention for Informal Caregivers to Manage the Challenging Behavior of People with Dementia (the insideDEM Study): Protocol for a Feasibility Study. JMIR Res Protoc, 2019, 8(2):e11630 (IF -)

12.  Diehl-Schmid J, Licata A, Goldhardt O, Förstl H, Yakushew I, Otto M, Anderl-Straub S, Beer A, Ludolph AC, Landwehrmeyer GB, Levin J, Danek A, Fliessbach K, Spottke A, Fassbender K, Lyros E, Prudlo J, Krause BJ, Volk A Edbauer D, Schroeter ML, Drzezga A, Kornhuber J, Lauer M; FTLDc Study Group, Grimmer T. FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations. Transl Psychiatry, 2019, 9(1): 54 (IF 5,47)

13.  Sakr FA, Grothe MJ, Cavedo E, Jelistratova I, Habert MO, Dyrba M, Gonzalez-Escamilla G, Bertin H, Locatelli M, Lehericy S, Teipel SJ, Dubois B, Hampel H; for the INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Applicability o in vivo staging of regional amylid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study. Alzheimers Res Ther, 2019, 11(1): 15 (IF 7,07)

14.  Wolfsgruber S, Molinuevo JL, Wagner M, Teunissen CE, Rami L, Coll-Padros N, Bouwman FH, Slot RER, Wesselmann LMP, Peters O, Luther K, Buerger K, Priller J, Laske C, Teipel SJ, Spottke A, Heneka MT, Düzel E, Drzezga A, Wiltfang J, Sikkes SAM, van der Flier WM, Jessen F; Euro-SCD working group. Prevalence of abnormal Alzheimer’s disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples. Alzheimers Res Ther, 2019, 11(1):8 (F 7,07)

15.  Kilimann I, Braungardt T, Thiel F, Hake K, Haufe C, Schneider W, Teipel SJ. Feasibility and effects of a psychotherapeutic group intervention for caregiving relatives of people with dementia. Z Gerontol Geriatr, 2019, epub ahead of print (IF 1,16)

16.  Zwingmann I, Michalowskiy B, Esser A, Kaczynski A, Monsees J, Keller A, Hertel J, Wucherer D, Thyrian JR, Eichler T, Kilimann I, Teipel S, Dreier Wolfgramm A, Hoffmann W. Identifying Unmet Needs of familiy dementia caregivers: results oft he baseline assessment of a cluster-randomized controlled intervention trial. J Alzheimers Dis, 2019, 67(2):527-539 (IF 3,48)

17.  Chiesa PA, Cavedo E, Grothe MJ, Houot M, Teipel SJ, Potier MC, Habert MO, Lista S, Dubois B, Hampel H; INSIGHT-preAD Study Group and the Alzheimer Precision Medicine Initiative (APMI). Relationship between basal forebrain resting-state functional connectivity and brain Amyloid-ß deposition in cognitively intact older adults with subjective memory complaints. Radiology, 2019, 290(1):167-176 (IF 7,30)

18.  Stenzel J, Rühlmann C, Lindner T, Polei S, Teipel SJ, Kurth J, Rominger A, Krause BJ, Vollmar B, Kuhla A. 18F-florbetaben PET/CT imaging in the Alzheimer’s disease mouse model APPswe/PS1dE9. Curr. Alzheimer Res, 2019, 16(1):49-55 (IF 3,29)

19.  Bischof GN, Ewers M, Franzmeier N, Grothe MJ, Hoenig M, Kocagoncu E, Neutzel J, Rowe JB, Strafella A, Drzezga A, van Eimeren T; MINC faculty. Connectomis and molecular imaging in neurodegeneration. Eur J Nucl Med Mol Imaging, 2019, 46(13):2819-2830 (IF 7,18)

20.  Bartrés-Faz D, González-Escamilla G, Vaqué-Alcázar L, Abellaneda-Pérez K, Valls-Pedret C, Ros E, Grothe MJ. Characterizing the Molecular Architecture of Cortical Regions Associated with High Educational Attainment in Older Individuals. J Neurosci, 2019, 39(23):4566-4575 (IF 6,07)

21.  Scherr M, Utz L, tahmasian M, Pasquini L, Grothe MJ, Rauschecker JP, Grimmer T, Drzezga A, Sorg C, Riedl V. Effective connectivity in the default mode network is distinctively disrupted in Alzheimer’s disease-A simultaneous resting-state FDG-PET/fMRI study. Hum Brain Mapp, 2019, e-pub ahead of print (IF 4,55)

22.  Fritz HJ, Ray N, Dyrba M, Sorg C, Teipel SJ, Grothe MJ. The corticotopic organization of the human basal forebrain as revealed by regionally selective functional connectivity profiles. Hum Brain Mapp, 2019, 40(3): 868-878 (IF 4,55)

23.  Düzel, E, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Betts M, Ziegler G, Chen Y, Dobisch L, Bittner D, Glanz W, Reuter M, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Nestor P, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Ramirez A, Schneider A, Kofler B, Speck O, Teipel S, Kilimann I, Dyrba M, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume. Alzheimers Dement (Amst), 2018, 10:782-790, (IF -)

24.  Scheef L, Grothe MJ, Koppara A, Daamen M, Boecker H, Biersack H, Schild HH, Wagner M, Teipel S, Jessen F. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD). Neuroimage Clin, 2019, epub ahead of print (IF 4,81)

25.  Hu X, Teunissen C, Spottke A, Heneka MT, Düzel E, Peters O, Li S, Priller J, Bürger K, Teipel SJ, Laske C, Verfaillie S, Barkhof F, Coll-Padrós N, Rami L, Molinuevo JL, van der Flier W, Jessen F. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer’s disease-Data from three memory clinic studies. Alzheimers Dement, 2019, 15(2): 185-193 (IF 14,42)

 

 

1.     Düzel, E, Berron D, Schütze H, Cardenas-Blanco A, Metzger C, Betts M, Ziegler G, Chen Y, Dobisch L, Bittner D, Glanz W, Reuter M, Spottke A, Rudolph J, Brosseron F, Buerger K, Janowitz D, Fliessbach K, Heneka M, Laske C, Buchmann M, Nestor P, Peters O, Diesing D, Li S, Priller J, Spruth EJ, Altenstein S, Ramirez A, Schneider A, Kofler B, Speck O, Teipel S, Kilimann I, Dyrba M, Wiltfang J, Bartels C, Wolfsgruber S, Wagner M, Jessen F. CSF total tau levels are associated with hippocampal novelty irrespective of hippocampal volume. Alzheimers Dement (Amst), 2018, 10:782-790, IF -)

2.      Scheef L, Grothe MJ, Koppara A, Daamen M, Boecker H, Biersack H, Schild HH, Wagner M, Teipel S, Jessen F. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD). Neuroimage Clin, 2019, epub ahead of print (IF 4,81)

3.      Hu X, Teunissen C, Spottke A, Heneka MT, Düzel E, Peters O, Li S, Priller J, Bürger K, Teipel SJ, Laske C, Verfaillie S, Barkhof F, Coll-Padrós N, Rami L, Molinuevo JL, van der Flier W, Jessen F. Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer’s disease-Data from three memory clinic studies. Alzheimers Dement, 2019, 15(2): 185-193 (IF 12,74)

4.      Steinacker P, Anderl-Straub S, Diel-Schmid J, Semler E, Uttner I, von Arnim CAF, Barthel H, Danek A, Fassbender K, Fliessbach K, Foerstl H, Grimmer T, Huppertz HJ, Jahn H, Kassubek J, Kornhuber J, Landwehrmeyer B, Lauer M, Maler JM, Mayer B, Oeckl P, Prudlo J, Schneider A, Volk AE, Wiltfang J, Schroeter ML, Ludolph AC, Otto M; FTLDc study group. Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology, 2018, 91(15):e1390-e1401 (IF 8,32)

5.      Cavedo E, Chiesa PA, Houot M, Ferretti MT, Grothe MJ, Teipel SJ, Lista S, Habert MO, Potier MC, Dubois B, Hampel H; INSIGHT-preAD Study Group; Alzheimer Predision Medicine Initiative (APMI). Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer’s disease in cognitively normal older adults with subjective memory complaints. Alzheimers Dement, 2018, 14(9): 1204-1215 (IF 12,74)

6.      Teipel SJ, Cavedo E, Hampel H, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative; Alzheimer Precision Medicine Initiative (APMI). Basal forebrain Volume, but not hippocampal volume, is a predictor of global cognitive decline in patients with Alzheimer’s disease treated with cholinesterase inhibitors. Front Neurol, 2018, 9:642 (IF 3,51)

7.      Grothe MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, Schöll M, Hansson O, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology. Brain, 2018, 141(9):2755-2771 (IF 10,85)

8.      Thyrian JR, Hertel J, Schulze LN, Dörr M, Prüss H, Hempel P, Bimmler M, Kunze R, Grabe JH, Teipel SJ, Hoffmann W. Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study. J Alzheimers Dis, 2018, 64(4):1091-1097 (IF 3,48)

9.      Wolf D, Tüscher O, Teipel SJ, Mierau A, Strüder H, Drzezga A, Baier B, Binder H, Fellgiebel A; German Age Gain study group. Mechanisms and modulators of cognitive training gain transfer in cognitively healthy aging: study protocol of the AgeGain study. Trials, 2018, 19(1):337 (IF 2,34)

10.    Teipel SJ, König A, Hey J, Kaye J, Krüger F, Robillard JM, Kirste T, Babiloni C. Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia. DADM, 2018, 14(9):1216-1231 (IF 0)

11.    Teipel SJ, Metzger C, Brosseron F, Buerger K, Brueggen K, Catak C, Diesing D, Dobisch L, Fließbach K, Franke C, Heneka MT, Kilimann I, Kofler B, Menne F, Peters O, Polcher A, Priller J, Schneider A, Spottke A, Spruth EJ, Thelen M, Thyrian RJ, Wagner M, Düzel E, Jessen F, Dyrba M; DELCODE study group. Multicenter resting state functional connectivity in prodromal and dementia stages of Alzheimer’s disease. J Alzheimers Dis, 2018, 64(3):801-813 (IF 3,48)

12.    Brueggen K, Dyrba M, Kilimann I, Henf J, Hoffmann W, Thyrian JR, Teipel SJ. Hippocampal mean diffusivity for the diagnosis of dementia and mild cognitive impairment in primary care. Curr Alzheimer Res, 2018, 15(11): 1005-1012 (IF 3,29)

13.    Strohmaier U, Keller F, Kilimann I, Michalowsky B, Wucherer D, Zwingmann I, Teipel SJ, Hoffmann W, Thyrian JR. Patients with dementia in primary care: Who is referred to a Neurologist/Psychiatrist and what patient-oriented factors are associated with the visit? J Alzheimers Dis, 2018, 64(3): 925-932 (IF 3,48)

14.    Teipel SJ, Cavedo E, Lista S, Habert MO, Potier MC, Grothe MJ, Epelbaum S, Sambati L, Gagliardi G, Toschi N, Greicius M, Dubois B, Hampel H; INSIGHT-preAD study group; Alzheimer Precision Medicine Initiative (APMI). Effect of Alzheimer’s disease risk and protective factors on cognitive trajectories in subjective memory complainers.  Alzheimers Dement., 2018, 14(9): 1126-1136 (IF 12,74)

15.    Semler E, Anderl-Straub S, Uttner I, Diehl-Schmid J, Danek A, Einsiedler B, Fassbender K, Fliessbach K, Huppertz JH, Jahn H, Kornhuber J, Landwehrmeyer B, Lauer M, Muche R, Prudlo J, SchneiderA, Schroeter ML, Ludolph AC, Otto M; FTLD consortium. A language-based sum score for the course and therapeutic intervention in primary progressive aphasia. Alzheimers Res Ther., 2018, 10(1):41 (IF 6,21)

16.    Buchert R, Lange C, Suppa P, Apostolova I, Spies L, Teipel SJ, Dubois B, Hampel H, Grothe MJ. Magnetic resonance imaging-based hippocampus volume for prediction of dementia in mild cognitive impairment: Why does the measurement method matter so little? Alzheimers Dement., 2018, 14(7): 976-978 (IF 12,74)

17.    Zwingmann I, Hoffmann W, Michalowsky B, Wucherer D, Eichler T, Teipel SJ, Dreier-Wolfgramm A, Kilimann I, Thyrian JR. Unmet needs of family dementia caregivers of persons with dementia: Primary medical care. Nervenarzt, 2018, 89(5): 495-499 (IF 0,87)

18.    Bohnen NI, Teipel SJ. Cholinergic forebrain density loss in Parkinson disease: More than just cognitive changes. Neurology, 2018, epub ahead of print (IF 8,32)

19.    Teipel SJ, Fritze T, Ellenrieder M, Haenisch B, Mittelmeier W, Doblhammer G. Association of joint replacement surgery with incident dementia diagnosis in German claims data. Int Psychogeriatr, 2018, 21:1-9 (IF 2,26)

20.    Bohnen NI, Grothe MJ, Ray NJ, Müller MLTM, Teipel SJ. Recent advances in cholinergic imaging and cognitive decline-Revisiting the cholinergic hypothesis of dementia. Curr Geriatr Rep, 2018, 7(1):1-11 (IF 0,77)

21.    Franzmeier N, Düzel E, Jessen F, Bürger K, Levin J, Duering M, Dichgans M, Haass C, Suárez-Calvet M, Fagan AM, Paumier K, Benzinger T, Masters CL, Morris JC, Perneczky R, Janowitz D, Catak C, Wolfsgruber S, Wagner M, Teipel SJ, Kilimann I, Ramirez A, Rossor M, Jucker M, Chhatwal J, Spottke A, Boecker H, Brosseron F, Falkai P, Fliessbach K, Heneka MT, Laske C, Nestor P, Peters O, Fuentes Mi, Menne F, Priller J, Spruth EJ, Franke C, Schneider A, Kofler B, Westerteicher C, Speck O, Wiltfang J, Bartels C, Araque Caballero MÀ, Metzger C, Bittner D, Weiner M, Lee JH, Salloway S, Danek A, Goate A, Schofield PR, Bateman RJ, Ewers M. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease. Brain 2018, 141(4): 1186-1200 (IF 10,85)

22.    Jessen F, Spottke A, Boecker H, Brosseron F, Buerger K, Catak C, Fliessbach K, Franke C, Fuentes M, Heneka MT, Jannowitz D, Kilimann I, Laske C, Menne F, Nestor P, Peters O, Priller J, Pross V, Ramirez A, Schneider A, Speck O, Spruth EJ, Teipel SJ, Vukovich R, Westerteicher C, Wilfang J, Wolfsgruber S, Wagner M, Düzel E. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer’s disease (DELCODE). Alzheimers Res Ther, 2018, 10(1): 15 (IF 6,21)

23.    Hampel H, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Melo Dos Santos A, Epelbaum S, Lamari F, Genthon R, Dubois B, Floris R, Garaci F, Lista S; Alzheimer Precision Medicine Initiative (APMI). Alzheimer’s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aß 1-42, total-tau, phosphorylated-tau, NFL, neurogranin and YKL-40. Alzheimers Dement, 2018, epub ahead of print (IF 12,74)

24.    Ray NJ, Bradburn S, Murgatroyd C, Tosseeb U, Mir P, Lountouriotis GK, Teipel SJ, Grothe MJ. In vivo cholinergic basal forebrain atrophy predicts dognitive decline in de novo Parkinson’s disease. Brain, 2018, 141(1):165-176 (IF 10,85)

25.    Zwingmann I, Hoffmann W, Michalowsky B, Dreier-Wolfgramm A, Hertel J, Wucherer D, Eichler T, Kilimann I, Thiel F, Teipel SJ, Thyrian JR. Supporting family dementia caregivers: testing the efficacy of dementia care management on multifaceted caregivers’ burden. Aging Ment Health, 2018, (7): 889-896 (IF 2,66) 

26.    Teipel SJ, Kilimann I, Thyrian JR, Klöppel S, Hoffmann W. Potential role of neuroimaging markers for early diagnosis of dementia in primary care. Curr Alzheimer Res., 2018, 15(1): 18-27 (IF 3,29)

27.    Eichler T, Thyrian JR, Hertel J, Richter S, Michalowsky B, Wucherer D, Dreier A, Kilimann I, Teipel SJ, Hoffmann W. Patient Variables Associated with the Assignment of a Formal Dementia Diagnosis to Positively Screened Primary care Patients. Curr. Alzheimer Res., 2018, 15(1):44-50 (IF 3,29)

28.    Dyrba M, Grothe MJ, Mohammadi A, Binder H, Kirste T, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging. J Alzheimers Dis, 2018, 65(3): 731-746 (IF 3,48)

1. Henf J, Grothe MJ, Brueggen K, Teipel SJ, Dyrba M. Mean diffusivity in cortical gray matter in Alzheimer’s Disease: The importance of partial volume correction. Neuroimage Clin, 2017, 17:579-586 (IF 4,35)

2. Teipel SJ, Bakardjian H, Gonzalez-Escamilla G, Cavedo E Weschke S, Dyrba M, Grothe MJ, Potier MC, Habert MO, Duboois B Hampel H; INSIGHT-preAD study group. No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints. Neuroimage Clin, 2017, 17:435-443 (IF 4,35)

3. Zwingmann I, Hoffmann W, Michalowsky B, Dreier-Wolfgramm A, Hertel J, Wucherer D, Eichler T, Kilimann I, Thiel F, Teipel SJ, Thyrian JR. Supporting family dementia caregivers: testing the efficacy of dementia care management on multifaceted caregivers’burden. Aging Ment Health, 2017, 20:1-8, epub ahead of print (IF 1,44)

4. Yordanova K, Koldrack P, Heine C, Henkel R, Martin M, Teipel SJ, Kirste T. Situation Model for Situation-Aware Assistance of Dementia Patients in Outdoor Mobility. J Alzheimers Dis, 2017, 60(4): 1461-1476 (IF 3,92 )

5.      Brueggen K, Fiala C, Berger C, Ochmann S, Babiloni C, Teipel SJ. Early changes in Alpha Band Power and DMN BOLD Activity in Alzheimer’s Disease: A simultaneous resting state EEG-FMRI study. Front Aging Neurosci, 2017, 9:319 (IF 4,72)

6. Grothe MJ, Barthel H, Sepulcre J, Dyrba M, Sabri O, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. In vivo staging o regional amyloid deposition. Neurology, 2017, 89(20): 2031-2038 (IF 8,32)

7. Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luchaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia. Alzheimers Res Ther, 2017, 9(1): 84 (IF 6,15)

8. Cavedo E, Grothe MJ, Colliot O, Lista S, Chupin M, Dormont D, Houot M, Lehéricy S, Teipel SJ, Dubois B, Hampel H; Hippocampus Study Group. Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease. Sci. Rep., 2017, 15;7(1):11706 (IF 4,85)

9. Müller S, Preische O, Göpfert JC, Yanez VAC, Joos TO, Boecker H, Düzel E, Falka P, Priller J, Bürger K, Catak C, Janowitz D, Heneka MT, Brosseron F, Nestor P, Peters O, Menne F, Schipke CG, Schneider A, Spottke A, Fließbach K, Kilimann I, Teipel SJ, Wagner M, Wiltfang J, Jessen F, Laske C. Tau plasma levels in subjective cognitive decline: Results from the DELCODE study. Sci Rep, 2017, 7(1):9529, (IF 4,85)

10. Michalowski B, Flessa S, Hertel J, Goertz O, Hoffmann W, Teipel SJ, Kilimann I. Cost of diagnosing dementia in a German memory clinic. Alzheimers Res Ther, 2017, 9(1):65 (IF 6,20)

11. Wucherer D, Thyrian JR, Eichler T, Hertel J, Kilimann I, Richter S, Michalowsky B, Zwingmann I, Dreier-Wolfgramm A, Ritter CA, Teipel SJ, Hoffmann W. Drug-related problems in community-dwelling primary care patients screened positive for dementia. Int. Psychogeriatr, 2017,(11):1857-1868 (IF 0,68)

12. Thyrian JR, Hertel J, Wucherer D, Eichler T, Michalowsky B, Dreier-Wolfgramm A, Zwingmann I, Kilimann I, Teipel SJ, Hoffmann W. Effectiveness and Safety of Dementia Care Management in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry, 2017, 74(10):996-1004 (IF 15,3)

13. Lista S, Toschi N. Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Nistico R, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI). Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study. J Alzheimers Dis, 2017, 59(4):1327-1334 (IF 3,92)

14. Dyrba M, Grothe MJ, Mohammadi A, Binder H, Kirste T, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging. J Alzheimers Dis, 2017, epub ahead of print (IF 3,92)

15. Kuhla A, Rühlmann C, Lindner T, Polei S, Hadlich S, Krause BJ, Vollmar B, Teipel SJ. APPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI study. Neuroimaging Clin, 2017, eCollection (IF 4,35)

16. Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G, Dauphinot L, Gonzalez-Escamilla G, Potier MC, Bertin H, Habert MO, Dubois B, Hampel H; INSIGHT-preAd study group. Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol. Aging, 2017, 57:143-152 (IF 5,12)

17. Frisoni G, Boccardi M, Barkhof F, Blennow K, Cappa S, Chiotis K, Démonet JF, Garibotto V, Giannakopoulos P, Gietl A, Hannson O, Herholz K, Jack Jr C R, Nobili F, Nordberg A, Snyder HM, Kate MT, Varrone A, Albanese E, Becker S, Bossuyt P, Carrillo MC, Cerami C, Dubois B, Gallo V, Giacobini E, Gold G, Hurst S, Lönneborg A, Lovblad KO, Mattson N, Molinuevo JL, Monsch AU, Mosimann U, Padovani A, Pico A, Porteri C, Ratib O, Saint-Aubert L, Scerri C, Scheltens P, Schott JM, Sonni I, Teipel SJ, Vineis P, Visser PJ, Yasui Y, Winblad B. Strategic roadmap for an early diagnosis of Alzheimer’s disease based on biomarkers. Lancet Neurol, 2017, 16:661-76 (IF 26,28)

18. Cavedo E, Lista S, Rojkova K, Andrea Chiesa P, Houot M, Brueggen K, Blautzik J, Bokde ALW, Dubois B, Barkhof F, Pouwels PJW, Teipel SJ, Hampel H; Alzheimer Precision Medicine Initiative (APMI). Disrupted white matter structural networks in healthy older adults APOE 4 carriers – An International Multicenter DTI Study. Neuroscience, 2017, 357:119-133 (IF 3,23)

19. Guo S, Lai C, Wu C, Cen G; Alzheimer’s Disease Neuroimaging Initiative. Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images. Front Aging Neurosci, 2017, 18;9:146 (IF4,72)

20. Lista S, Toschi N, Baldacci F, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Hampel H; Alzheimer Precision Medicine Initiative (APMI). Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer’s disease. Neurochem Int, 2017, 108:355-360 (IF3,39)

21. Gollan JK, Dong H, Bruno D, Nierenberg J, Nobrega JN, Grothe MJ, Pollock BG, Marmar CR, Teipel SJ, Csernansky JG, Pomara N. Basal forebrain mediated increase in brain CRF is associated with increased cholinergic tone and depression. Psychiatry Res, 2017, 264:76-81 (IF2,47)

22. Teipel SJ, Heine C, Hein A, Krüger F, Kutschke A, Kernebeck S, Halek M, Bader S, Kirste T. Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes – The insideDEM framework. Alzheimers Dement, Diagnosis Assessment & Monitoring, 2017, 4;8:36-44 (IF2,50)

23. Kilimann I, Thyrian JR, Hoffmann W, Teipel SJ. Translation of imaging biomarkers from clinical research to healthcare. Z Gerontol. Geriatr, 2017, 50 (Suppl 2):84-88 (IF 0,77)

24.    Ochmann S, Dyrba M, Grothe MJ, Kasper E, Webel S, Hauenstein K, Teipel SJ. Does functional Connectivity Provide a Marker for Cognitive Rehabiliation Effects in Alzheimer’s disease? An Interventional Study. J Alzheimers Dis, 2017, 57(4):1303-1313 (IF 3,92)

25.    Brüggen K, Kasper E, Ochmann S, Pfaff H, Webel S, Schneider W, Teipel SJ. Cognitive Rehabilitation in Alzheimer’s Disease: A Controlled Intervention Trial. J. Alzheimer’s Dis, 2017, 57(4):1315-1324 (IF 3,92)

26. Liu Q, Zhu Z, Teipel SJ, Yang J, Xing Y, Tang Y, Jia J. White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia, Front Aging Neurosci, 2017, 9:47 (IF 4,35)

27. Baldacci F, Toschi N, Lista S, Zetterberg H, Blennow K, Kilimann I, Teipel SJ, Cavedo E, Dos Santos AM, Epelbaum S, Lamari F, Dubois B, Floris R, Garaci F, Bonuccelli U, Hampel H. Two-Level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer’s disease., Alzheimers Dement, 2017, 13(9): 993-1003 (IF 11,62)

28. Teipel SJ, Wohlert A, Metzger CD, Grimmer T, Sorg C, Ewers M, Meisenzahl E, Klöppel S, Borchardt V, Grothe MJ, Walter M, Dyrba M: Multicenter stability of resting state fMRI in the detection of Alzheimer’s disease and amnestic MCI. Neuroimagin Clin, 2017, 14:183-194 (IF 4,35) 

29. Teipel SJ, Grothe MJ, Metzger CD, Grimmer T, Sorg C, Ewers M, Franzmeier N, Meisenzahl E, Klöppel S, Borchardt V, Walter M, Dyrba M (2017): Robust Detection of Impaired Resting State Functional Connectivity Networks in Alzheimer's Disease Using Elastic Net Regularized Regression. Front. Aging Neurosci., 2017, 8:318. doi: 10.3389/fnagi.2016.00318 (IF 4,35)

30.    Teipel SJ, Keller F, Thyrian JR, Strohmaier U, Altiner A, Hoffmann W, Kilimann I. Hippocampus and basal forebrain volumetry for dementia and mild cognitive impairment diagnosis: Could it be useful in primary care? J Alzheimers Dis, 2017, 55(4):1379-1394 (IF 3,92)

31. Wucherer D, Eichler T, Hertel J, Kilimann I, Richter S, Michalowsky B, Thyrian JR, Teipel SJ, Hoffmann W. Potentially inappropriate medication in community-dwelling primary care patients who were screened positive for dementia. J Alzheimers Dis, 2017, 55(2):691-701 (IF 3,27)

32. Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, Agosta F, Nestor P, Meisenzahl E, Blautzik J, Frölich L, Hausner L, Bokde AL, Frisoni G, Pievani M, Klöppel S, Prvulovic D, Barkhof F, Pouwels PJ, Schröder J, Hampel H, Hauenstein K, Teipel SJ. The European DTI Study on Dementia – a multicenter DTI and MRI study on AD and MCI. Neuroimage, 2017, 144(Pt B):305-308 (IF 5,46)

33. Kilimann I, Hausner L, Fellgiebel A, Filippi M, Würdemann TJ, Heinsen H, Teipel SJ. Parallel Atrophy of Cortex and Basal Forebrain Cholinergic System in Mild Cognitive Impairment, Cereb Cortex, 2017, 27(3): 1841-1848 (IF 8,23)

34. Franzmeier N, Buerger K, Teipel SJ, Stern Y, Dichgans M, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Cognitive reserve moderates the association between functional network anti-correlations and memory in MCI. Neurobiol Aging, 2017, 50:152-162 (IF 5,15)

35. Gonzalez-Escamilla G, Lange C, Teipel SJ, Buchert R, Grothe MJ, for the Alzheimer’s Disease Neuroimaging Initiative. PETPVE12: an SPM toolbox for partial volume effects correction in brain PET – application to amyloid imaging with AV45-PET. Neuroimage, 2017, 147:669-677 (IF 5,46)

1.     Brueggen K, Kasper E, Dyrba M, Bruno D, Pomara N, Ewers M, Duering M, Bürger K, Teipel SJ. The primacy effect in amnestic mild cognitive impairment: associations with hippocampal functional connectivity. Front Aging Neurosci, 2016, 8:244 (IF 4,35)

2.     Kasper E, Brueggen K, Grothe MJ, Bruno D, Pomara N, Unerauer E, Duering M, Ewers M, Teipel SJ, Buerger K. Neuronal Correlates of Serial Position Performance in Amnestic Mild Cognitive Impairment. Neuropsychology, 2016, 30(8):906-914 (IF 2,88)

3.     Teipel SJ, Raiser T, Riedl L, Riederer I, Schroeter ML, Bisenius S, Schneider A, Kornhuber J, Fliessbach K, Spottke A, Grothe MJ, Prudlo J, Kassubek J, Ludolph A, Landwehrmeyer B, Straub S, Otto M, Danek A; FTLDc study group. Atrophy and structural covariance oft he cholinergic basal forebrain in primary progressive aphasia. Cortex, 2016, 83: 124-135 (IF 4,31)

4.     Schönecker S, Brendel M, Huber M, Vollmar C, Huppertz HJ, Teipel SJ, Okamura N, Levin J, Rominger A, Danek A. Applied multimodal diagnostics in a case of presenile dementia. BMC Neurol, 2016, 16:131 (IF 1,96)

5.     Prudlo J, König J, Schuster C, Kasper E, Büttner A, Teipel SJ, Neumann M. TDP-43pathology and cognition in ALS: A prospective clinicopathologic correlation study. Neurology, 2016, 87(10):1019-23 (IF 8,17)

6.     Fritze T, Teipel SJ, Ovari A, Kilimann I, Witt G, Doblhammer G. Hearing Impairment Affects Dementia Incidence. An Analysis based on longitudinal health claims data in Germany. Plos One, 2016, 11(7):e0156876 (IF 3,06)

7.     Peter J, Lahr J, Minkova L, Lauer E. Grothe MJ, Teipel SJ, Köstering L, Kaller CP, Heimbach B, Hüll M, Normann C, Nissen C, Reis J, Klöppel S. Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment. J Alzheimers Dis, 2016, 53(3):991-1001(IF 3,92)

8.     Bruno D, Ciarleglio A, Grothe MJ, Nierenberg J, Bachman AH, Teipel SJ, Petkova E, Ardekani BA, Pomara N. Hippocampal volume and integrity as predictors of cognitive decline in intact elderly. Neuroreport, 2016, 27(11):869-73 (IF 1,52)

9.     Teipel SJ, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Association between smoking and cholinergic basal forebrain volume in healthy aging and prodromal and dementia stages of AD. J Alzheimers Dis, 2016, 52(4):1443-51 (IF 3,92)

10.  Eichler T, Thyrian JR, Hertel J, Richter S, Wucherer D, Michalowsky B, Teipel SJ, Kilimann I, Dreier A, Hoffmann W. Unmet Needs of Community-Dwelling Primary Care patients with Dementia in Germany: Prevalence and Correlates. J Alzheimers Dis, 2016, 51(3):847-55 (IF 3,92)

11.  Teipel SJ, Grothe MJ, Zhou J, Sepulcre J, Dyrba M, Sorg C, Babiloni C. Measuring Cortical Connectivity in AD as a Brain Neural Network Pathology: Toward Clinical Applications. J Int Neuropsychol Soc., 2016, 22(2):138-63 (IF 2,63)

12.  Teipel SJ, Cavedo E, Grothe MJ, Lista S, Galluzzi S, Colliot O, Chupin M, Bakardjian H, Dormont D, Dubois B, Hampel H; Hippocampus Study Group. Predictors of cognitive decline and treatment response in a clinical trial on suspected prodromal Alzheimer’s disease. Neuropharmacology, 2016, 108:128-35 (IF 4,94)

13.  Bokde AL, Cavedo E, Lopez-Bayo P, Lista S, Meindl T, Born C, Galluzzi S, Faltraco F, Dubois B, Teipel SJ, Reiser M, Möller HJ, Hampel H. Effects of rivastigmine on visual attention in subjects with amnestic mild cognitive impairment: a serial functional MRI activation pilot-study. Psychiatry Res, 2016, 249:84-90 (IF 2,47)

14.  Blautzik J, Keeser D, Paolini M, Kirsch V, Berman A, Coates U, Reiser M, Teipel SJ, Meindl T. Functional connectivity increase in the default-mode network of patients with Alzheimer’s disease after long-term treatment with Galantamine. Eur Neuropsychopharmacol, 2016, 26(3):602-13 (IF 4,41)

15.  Teipel SJ, Babiloni C. Hoey J, Kaye J, Kirste T, Burmeister OK. Information and communication technology solutions for outdoor navigation in dementia. Alzheimers Dement, 2016, 12(6):695-700 (IF 12,41)

16.  Müller HP, Turner MR, Grosskreutz J, Abrahams S, Bede P, Govind V, Prudlo J, Ludolph AC, Filippi M, Kassubek J; Neuroimaging Society in ALS (NiSALS) DTI Study Group. A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry, 2016, 87(6):570-9 (IF 6,81)

17.  Bruno D, Grothe MJ, Nierenberg J, Siditis JJ, Teipel SJ, Pomara N. Output order and variability in free recall are linked to cognitive ability and hippocampal volume in elderly individuals. Neuropsychologia, 2016, 8;80:126-132 (IF 2,99)

18.  Grothe MJ, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Spatial patterns of atrophy, hypometabolism and amyloid deposition in Alzheimer’s disease correspond to dissociable functional brain networks. Hum Brain Mapp, 2016, 37(1):35-53 (IF 4,96)

19.  Teipel SJ; Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of AD? Eur J Nucl Med Mol Imaging, 2016, 43(3):526-36 (IF 5,38 )

20.  Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, Benecke R, Vielhaber S, Teipel SJ, Prudlo J. No Change in Executive Perfomance in ALS patients: A Longitudinal Neuropsychological Study. Neurodegener Dis, 2016, 16(3-4):184-91 (IF 3,51)

21.  Grothe MJ, Heinsen H, Amaro E Jr, Grinberg LT, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment, Cereb Cortex, 2016, 26(6):2411-26 (IF 8,29)

  1. Kasper E, Zydatiss K, Schuster C, Machts J, Bittner D, Kaufmann J, Benecke R, Vielhaber S, Teipel SJ, Prudlo J. No Change in Executive Perfomance in ALS patients: A Longitudinal Neuropsychological Study. Neurodegener Dis, 2015, e-pub ahead of print (IF 3,51)
  2. Bruno D, Grothe MJ, Nierenberg J, Siditis JJ, Teipel SJ, Pomara N. Output order and variability in free recall are linked to cognitive ability and hippocampal volume in elderly individuals. Neuropsychologia, 2015, 22;80:126-132 (IF 3,30)
  3. Lista S, Molinuevo JL, Cavedo E, Rami L, Amouyel P, Teipel SJ, Garaci F, Toschi N, Habert MO, Blennow K, Zetterberg H, O’Bryant SE, Johnson L, Galluzzi S, Bokde AL, Herholz K, Bakardijan H, Dubois B, Jessen F, Carrillo MC, Aisen PS, Hampel H. Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline. J Alzheimers Dis, 2015, 48 Suppl 1:171-91 (IF 4,15)
  4. Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer’ Disease in Patients with Mild Cognitive Impairment – A Multicenter DTI and Volumetry Study. J Alzheimers Dis, 2015, 48(1): 197-204 (IF 4,15)
  5. Klöppel S, Peter J, Ludl A, Pilatus A, Maier S, Mader I, Heimbach B, Frings L, Egger K, Dukart J, Schroeter ML, Perneczky R, Häussermann P, Vach W, Urbach H, Teipel SJ, Hüll M, Abdulkadir A. Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study. J Alzheimers Dis, 2015, 47(4): 939-54 (IF 4,15)
  6. Kasper E, Thöne-Otto A, Bürger K, Schröder SG, Hoffmann W, Schneider W, Teipel SJ. Cognitive rehabilitation in early stage Alzheimer’s disease. Nervenarzt, 2015, e-pub ahead of print (IF 0,79)
  7. Teipel SJ, Drzezga A, Grothe M, Barthel H, Chételat G, Schuff N, Skudlarski P, Cavedo E, Frisoni GB, Hoffmann W, Thyrian R, Fox C, Minoshima S, Sabri O, Fellgiebel A. Multimodal imaging in Alzheimer’s disease: validity and usefulness for early detection. Lancet Neurol, 2015, 14(10): 1037-53 (IF 21,90)
  8. Bruno D, Grothe MJ, Nierenberg J, Teipel SJ, Zetterberg h; Blennow K, Pomara N. The relationship between CSF tau markers, hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Alzheimers Dement, 2015, 1(1): 81-86 (IF 12,41)
  9. Doblhammer G, Fritze T. Month of birth and dementia late in life. Köln Z Soziol, 2015, Suppl. 67:217-240 (IF )
  10.  Koldrack P, Henkel R, Krüger F, Teipel SJ, Kirste T. Supporting Situation Awareness of Dementia Patients in Outdoor Environments. 2015, Paper presented at the Pervasive Health
  11. Koldrack P, Henkel R, Zarm K, Teipel SJ, Kirste T. Situationsadaptive Navigationsassistenz für Menschen mit Demenz, 2015, Paper presented at the AAL Kongress
  12. Teipel SJ, Fritze T, Ovari A, Buhr A, Kilimann I, Witt G, Pau HW, Doblhammer G. Regional Pattern of Dementia and Prevalence of Hearing Impairment in Germany. J AM Geriatr Soc, 2015, 63(8): 1527-33 (IF 4,57)
  13. Teipel SJ, Kurth J, Krause B, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. The relative importance of imaging markers for the prediction of AD dementia in mild cognitive impairment – beyond classical regression. Neuroimage Clin, 2015, 8:583-593 (IF 2,53)
  14. Doblhammer G, Fink A, Fritze T. Short-term trends in dementia prevalence in Germany between the years 2007 and 2009. Alzheimers Dement, 2015, 11(3): 291-9 (IF 12,41)
  15. Kasper E, Ochmann S, Hoffmann W, Schneider W, Cavedo E, Hampel H, Teipel SJ. Cognitive Rehabilitation in Alzheimer’s Disease – a conceptual an d methodological review. J Prev Alz Dis, 2015, (2)2:142-152 (IF 4,15)
  16. Morgen K, Schneider M, Frölich L, Tost H, Plichta MM, Kölsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, Teipel SJ, Pantel J, Heuser I, Wiltfang J, Rüther E, Kornhuber J, Maier W, Meyer-Lindenberg A. Apoliprotein E-dependent load of white matter hyperintensities in AD: a voxel-based lesion mapping study, Alzheimers Res Ther, 2015, 15;7(1):27 (IF 3,50)
  17. Teipel SJ, Grothe MJ, Wittfeld K, Hoffmann W, Hegenscheid K, Völzke H, Homuth G, Grabe HJ. Association of a neurokinin 3 receptor polymorphism with the anterior basal forebrain, Neurobiol Aging, 2015, 36(6): 2060-7 (IF 4,85)
  18. Kasper E, Schuster C, Machts J, Bittner D, Vielhaber S, Benecke R, Teipel SJ, Prudlo J. Dysexecutive functioning in ALS patients and its clinical implications, Amyotroph Lateral Scler Frontotemporal Degener, 2015, 16(3-4):160-71 (IF 2,59)
  19. Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium, Teipel SJ, Perneczky R, Hakonarson H, Hampel H, von Arnim CA, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L. The role of TREM2 R47H as a risk factor for Alzheimer’s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis and Parkinson’s disease, Alzheimers Dement, 2015, e-pub ahead of print (IF 17,47)
  20. Grothe MJ, Heinsen H, Amaro E Jr, Grinberg LT, Teipel SJ; Alzheimer’s Disease Neuroimaging Initiative. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment, Cereb Cortex, 2015, e-pub ahead of print (IF 8,31)
  21. Thyrian JR, Eichler T, Hertel J, Wucherer D, Dreier A, Michalowsky B, Kilimann I, Teipel SJ, Hoffmann W. Burden of Behavioral and Psychiatric Symptoms in People Screened Positive for Dementia in Primary Care: Results of the DelpHi-Study. J Alzheimers Dis, 2015, e-pub ahead of print (IF 4,17)
  22. Boccardi M, Bocchetta M, Morency FC, Collins DL, Nishikawa M, Ganzola R, Grothe MJ, Wolf D, Redolfi A, Pievani M, Antelmi L, Fellgiebel A, Matsuda H, Teipel SJ, Duchesne S, Jack CR Jr., Frisoni GB; EADC-ADNI Working Group on The Harmonized Protocol for Manual Hippocampa Segmentation and for the Alzheimer’s Disease Neuroimaging Initiative. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol, Alzheimers Dement, 2015, 11(2): 175-83 (IF 17,47)
  23. Ray NJ, Metzler-Baddeley C, Khondoker MR, Grothe MJ, Teipel SJ, Wright P, Heinsen H, Jones DK, Aggleon JP, O’Sullivan MJ. Cholinergic basal forebrain structure influences the reconfiguration of white matter connections to support residual memory in MCI, J Neurosci, 2015, 35(2): 739-47 (IF 6,75)
  24. Dyrba M, Grothe M, Kirste T, Teipel SJ, Multimodal Analysis of Functional and Structural Disconnection in AD Using Multiple Kernel SVM, Human Brain Map, 2015, e-pub ahead of print (IF 6,92)
  25. Dyrba, M., Barkhof, F., Fellgiebel, A., Filippi, M., Hausner, L., Hauenstein, K., Kirste, T., Teipel, S. J. and the EDSD study group (2015), Predicting Prodromal Alzheimer's Disease in Subjects with Mild Cognitive Impairment Using Machine Learning Classification of Multimodal Multicenter Diffusion-Tensor and Magnetic Resonance Imaging Data. Journal of Neuroimaging, 2015, epub ahead of print (IF 1,82)
  26. Bruno D, Grothe MJ, Nierenberg J, Zetterberg H, Blennow K, Teipel SJ, Pomara N. A study on the specificity of the association between hippocampal volume and delayed primacy performance in cognitively intact elderly individuals. Neuropsychologia, 2015, 69, 1-8 (IF 3,45)
  27. Teipel SJ, Thyrian JR, Hertel J, Eichler T, Wucherer D, Michalowsky B, Kilimann I, Hoffmann W. Neuropsychiatric symptoms in people screened positive for dementia in primary care. Int Psychogeriatr, 2015, 27(1): 39-48 (IF 1,89)
  28. Eichler T Wucherer D, Thyrian JR, Kilimann I, Hertel J, Michalowsky B, Teipel SJ, Hoffmann W. Antipsychotic Drug Treatment in Ambulatory Dementia Care: Prevalence and Correlates. J Alzheimers Dis, 2015, 43(4): 1303-11 (IF 4,17)
  29. Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, Teipel S, Hoffmann W. Antidementia Drug Treatment in people screened positive for dementia in primary care. J Alzheimers Dis, 2015, 44(3): 1015-21 (IF 4,17)
  30. Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC -European Alzheimer's Disease Consortium and the ADNI - Alzheimer's Disease Neuroimaging Initiative. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement. 2015, 11(2):111-25 (IF17,47)
  31. Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel SJ, Prudlo J. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS – an in vivo study using DTI. PloS One, 2014, 9(12):e114543 (IF 4,09)
  32. Machts J, Bittner, V, Kasper E, Schuster C, Prudlo J, Abdulla S, Kollewe K, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Bittner DM. Memory deficits in ALS are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci, 2014, 15:83 (IF 6,75)
  33. Teipel S, Ehlers I, Erbe A, Holzmann C, Lau E, Hauenstein K, Berger C. Structural Connectivity changes underlying altered working memory networks in mild cognitive impairment: a three-way image fusion analysis. J Neuroimaging, 2014, epub ahead of print (IF 1,82)
  34. Berger C, Erbe A, Ehlers I, Marx I, Hauenstein K, Teipel S. Effects of task-irrelevant emotional stimuli on working memory processes in MCI. J Alzheimers Dis, 2015, 44(2): 439-53 (IF 4,17)
  35. Kilimann I, Ovari A, Hermann A, Witt G, Pau HW, Teipel SJ. Hearing impairment and dementia. Z  Gerontol Geriatr, 2015, 48(5): 440-5 (IF 1,02)

 

 

  1. Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel SJ, Prudlo J. Microstructural white matter changes underlying cognitive and behavioural impairment in ALS – an in vivo study using DTI. PloS One, 2014, 9(12):e114543 (IF 4,09)
  2. Machts J, Bittner, V, Kasper E, Schuster C, Prudlo J, Abdulla S, Kollewe K, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, Bittner DM. Memory deficits in ALS are not exclusively caused by executive dysfunction: a comparative neuropsychological study of amnestic mild cognitive impairment. BMC Neurosci, 2014, 15:83 (IF XX)
  3. Wucherer D, Eichler T, Kilimann I, Hertel J, Michalowsky B, Thyrian JR, Teipel S, Hoffmann W. Antidementia Drug Treatment in people screened positive for dementia in primary care. J Alzheimers Dis, 2014, epub ahead of print (IF 4,17)
  4. Teipel S, Ehlers I, Erbe A, Holzmann C, Lau E, Hauenstein K, Berger C. Structural Connectivity changes underlying altered working memory networks in mild cognitive impairment: a three-way image fusion analysis. J Neuroimaging, 2014, epub ahead of print (IF 1,82)
  5. Berger C, Erbe A, Ehlers I, Marx I, Hauenstein K, Teipel S. Effects of task-irrelevant emotional stimuli on working memory processes in MCI. J Alzheimers Dis, 2014, epub ahead of print (IF 4,17)
  6. Endres K, Fahrenholz F, Lotz J, Hiemke C, Teipel S, Lieb K, Tüscher O, Fellgiebel A. Increased CSF APPs-ß levels in patients with Alzheimer disease treated with acitretin. J Neurol, 2014, 83(21): 1930-5 (IF 3,58)
  7. Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, Preboske G, Swihart T, Blair M, Cavedo E, Grothe MJ, Lanfredi M, Martinez O, Nishikawa M, Portegies M, Stoub T, Ward C, Apostolova LG, Ganzola R, Wolf D, Barkhof F, Bartzokis G, DeCarli C, Csernansky JG, deToledo-Morrell L, Geerlings MI, Kaye J, Killiany RJ, Lehéricy S, Matsuda H, O'Brien J, Silbert LC, Scheltens P, Soininen H, Teipel S, Waldemar G, Fellgiebel A, Barnes J, Firbank M, Gerritsen L, Henneman W, Malykhin N, Pruessner JC, Wang L, Watson C, Wolf H, deLeon M, Pantel J, Ferrari C, Bosco P, Pasqualetti P, Duchesne S, Duvernoy H, Boccardi M; EADC -European Alzheimer's Disease Consortium and the ADNI - Alzheimer's Disease Neuroimaging Initiative. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement. 2014, epub ahead of print (IF14,48)
  8. Kilimann I, Ovari A, Hermann A, Witt G, Pau HW, Teipel SJ. Hearing impairment and dementia. Z  Gerontol Geriatr, 2014, epub ahead of print (IF 1,02)
  9. Grothe M, Schuster C, Bauer F, Heinsen H, Prudlo J, Teipel SJ. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J. Neurol. 2014, 261(10): 1939-48 (IF 3,58)
  10. Schwarzer C, Siatkowski M, Pfeiffer MJ, Baeumer N, Drexler HC, Wang B, Fuellen G, Boiani M. Maernal age effect on mouse oocytes: new biological insight from proteomic analysis. Reproduction, 2014, 148(1): 55-72 (IF 3,56)
  11. Schuster C, Kasper E , Machts J, Bittner D, Kaufmann J, Benecke R, Teipel SJ , Vielhaber S, Prudlo J . Longitudinal course of cortical thickness decline in amyotrophic lateral sclerosis. Journal of Neurology. 2014, epub ahead of print (IF 3,58)
  12. Teipel SJ, Lerche M, Kilimann I , O’Brien K, Grothe M , Meyer P, Li X, Sänger P, Hauenstein KH. Decline of fiber tract integrity over the adult age range – a diffusion spectrum imaging study. J Magn Reson Imaging. 2014, epub ahead of print (IF 2,57)
  13. Eichler T, Thyrian RJ, Hertel J, Köhler L, Wucherer D, Dreier A, Michalowsky B, Teipel SJ, Hoffmann W. Rates of Formal diagnosis in People Screened Positive for Dementia in Primary Care: results of the DelpHi-Trial. J Alzheimers Dis., 2014, epub ahead of print (IF 4,174)
  14. Kljajevic V, Grothe MJ , Ewers M, Teipel SJ. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer:s disease. Neurobiol Aging, 2014, 35(9): 1973-81
  15. Morgen K, Ramirez A, Frölich L, Tost H, Plichta MM, Kölsch H, Ragebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, Teipel SJ , Pantel J, Heuser I, Wiltfang J, Rüther E, Kornhuber J, Maier W, Meyer-Lindenberg A. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer’s disease. Alzheimers Dement, 2014, epub ahead of print (IF 14,483)
  16. Teipel SJ , Walter M, Likitjaroen Y, Schönknecht P, Gruber O. Diffusion tensor imaging in AD and affective disorders. Eur Arch Psych Clin Neurosci, 2014, epbub ahead of print (IF 3,200)
  17. Teipel SJ, Grothe MJ , Filippi M, Fellgiebel A, Dyrba M , Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K. Fractional Anisotropy Changes in AD Depend on the Underlying Fiber Tract Architecture: A Multiparametric DTI Study using Joint Independent Component Analysis. J Alzheimers Dis., 2014, 41(1): 69-83 (IF 4,174)
  18. Kilimann I , Grothe M , Heinsen H, Alho EJ, Grinberg L, Amaro Jr E, Dos Santos GA, da Silva RE, Mitchell AJ, Frisoni GB, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Kloppel S, Teipel SJ ; Subregional basal forebrain atrophy in Alzheimer's disease: A multicenter study. J Alzheimers Dis, 2014, 40(3): 687-700 (IF 4,174)
  19. Petersen S, Zimmermann U, Schmidt C, Schwabe L, Warkentin M, Teipel SJ ; Linking a neural mass model with a 3d model of the human brain to reproduce EEG signals. Biomed Tech (Berl), 2014, 59(3): 231-40 (IF 1,16)
  20. Teipel S , Heinsen H, Amaro E, Jr., Grinberg LT, Krause B, Grothe M , Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease. Neurobiol Aging, 2014, 35(3):482-9 (IF 6,166)
  21. Grothe MJ , Ewers M, Krause B, Heinsen H, Teipel SJ ; Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects. Alzheimer’s Disease Neuroimaging Initiative, Alzheimers Dement, 2014, epub ahead of print (IF 14,483)
  22. Kirste T, Hoffmeyer A, Koldrack P , Bauer A, Schubert S , Schröder S, Teipel SJ; Detecting the effect of Alzheimer’s disease on everyday motion behavior. J Alzheimers Dis, 2014, 38(1): 121-32 (IF 4,174)
  23. Wolf D, Grothe M , Fischer FU, Heinsen H, Kilimann I , Teipel S , Fellgiebel A. Association of basal forebrain volumes and cognition in normal aging. Neuropsychologia, 2014, 53: 54-64 (IF 3,477)
  24. Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel SJ , Vielhaber S, Prudlo J ; Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiology of Aging 2014, 35(1): 240-6 (IF 6,166)
  25. Teipel SJ , Flatz W, Ackl N, Grothe M, Kilimann I , Bokde AL, Grinberg L, Amaro E Jr, Kljajevic V, Alho E, Knels C, Ebert A, Heinsen H, Danek A; Brain atrophy in primary progressive aphasia involves the cholinergic basal forebrain and Ayala’s nucleus. J Psychiatr Res, 2014, 221(3): 187-94 (IF 4,066)
  26. Hampel H, Lista S, Teipel SJ , Garaci F, Nistico R, Blennow K, Zetterberg H, Bertram L, Duyckaerts C, Bakardijan H, Drzezga A, Colliot O, Epelbaum S, Broich K, Lehericy S, Brice A, Khachaturian ZS, Aisen PS, Dubois B. Perspective on future role of biological markers in clinical therapy trials of AD: a long-range point of view beyond 2020. Biochem Pharmacol, 2014, 88(4):426-449 (IF 4,576)
  27. Kasper E , Wegrzyn M, Marx I, Korp C , Kress W, Benecke R, Teipel SJ , Prudlo J . Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy’s disease. Amyotroph Lateral Scler Frontotemporal Degener, 2014, 15(1-2): 15-20 (IF 3,091)
  28. Kopczak A, Kilimann I , von Rosen F, Krewer C, Schneider HJ, Stalla GK, Schneider M. Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrahage. J Neurotraum 2014, 31 (1): 99-107 (IF 4,295)
  29. Kljajevic V , Meyer P, Holzmann C, Dyrba M, Kasper E , Bokde AL, Fellgiebel A, Meindl T, Hampel H, Teipel SJ ; EDSD study group. The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease. Alzheimers Dement. 2014, 10(3): 401-404 (IF 14,483)
  30. Lista S , Garaci FG, Ewers M, Teipel S , Zetterberg H, Blennow K, Hampel H. CSF Aß1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer’s disease. Alzheimers Dement., 2014, 10(3): 381-392 (IF 14,483)
  31. Doblhammer, G., Fink, A., Fritze, T . Short-Term Trends in Dementia Prevalence in Germany Between the Years 2007 and 2009, Alzheimer’s & Dementia 2014, accepted (IF 14,483)
  32. Fritze, T., Doblhammer, G ., van den Berg, G.: Effects of Earliest Life and Childhood Circumstances on Cognitive Functioning at Old Age: A Life Course Perspective Based on the First Three Waves of SHARE, 2014, Soc Sci & Med, revise & resubmit (IF 2,733)
  33. Doblhammer G, Fritze T, Teipel S. Regional Patterns of Dementia in Germany and Their Relationship with Chronic Disease, CPoS, 2014, Special Issue, under review (IF -)
  34. Doblhammer G ., van den Berg, G.J., Fritze T . Economic Conditions at the Time of Birth and Cognitive Abilities Late in Life: Evidence from Ten European Countries, PLOS ONE, 2014, 8(9): e74915, accepted (IF 4,09)
  35. Siatkowski M, Liebscher V, Fuellen G. Cell Fate Scout – a bioinformatics tool for elucidating small molecule signaling pathways that drive cells in a specific direction. J Cell Commun Signal, 2014, 11:85 doi: 10.1186/1478-811X-11185, epub ahead of print (IF 5,09)
  36. Rozwadowska N, Kolanowski T, Wiland E, Siatkowski M , Pawlak P, Malcher A, Mietkiewski T, Olszewska M, Kurpisz M. Characterisation of nuclear architectural alterations during in vitro differentiation of human stem cells of myogenic origin. Plos One, 2014, 8(9): e73231, epub ahead of print (IF 4,09)
  1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Bryne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I , Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel SJ , Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; Standards for Reporting Vascular changes on nEuroimaging (STRIVEv1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neuro., 2013, 12(8):822-38 (IF 23,917)
  2. Schuster C, Kasper E , Machts J, Bittner D, Kaufmann J, Benecke R, Teipel SJ , Vielhaber S, Prudlo J ; Focal thinning of the motor cortex mirrors clinical features of amyotrophic lateral sclerosis and their phenotypes: a neuroimaging study. J Neurol 2013, 260(11): 2856-64 (IF 3,578)
  3. Teipel SJ , Grothe M, Lista S , Toschi N, Garaci FG, Hampel H. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin North Am. 2013, 97(3):399-424 (IF 2,47)
  4. Bertsch k, Grothe M , Prehn K, Vohs K, Berger C, Hauenstein K, Keiper P, Domes G, Teipel SJ , Herpertz SC. Brain volumes differ between diagnostic groups of violent criminal offenders. Eur Arch Psychiatry Clin Neurosci, 2013, 263(7):593-606 (IF 3,494)
  5. Kilimann I , Likitjaroen Y, Hampel H, Teipel S . Diffusion tensor imaging to determine effects of antidementive treatment on cerebral structural connectivity in Alzheimer's disease. Curr Pharm Design. 2013, 19(36):6416-25 (IF 3,311)
  6. Fiß Th, Thyrian JR, Wucherer D, Aßmann G, Kilimann I, Teipel SJ, Hoffmann W . Medication management for primary care patients with dementia: a study protocol. J BMC Geriatrics, 2013, 13:121 (IF - )
  7. de Souza Silva MA, Lenz B, Rotter A, Biermann T, Peters O, Ramirez A, Jessen F, Maier W, Hüll M, Schröder J, Frölich L, Teipel S , Gruber O, Kornhuber J, Huston JP, Müller CP, Schäble S. Neurokinin 3 receptor as a target to predict and improve learning and memory in the aged organism. Proc Natl Acad Si USA, 2013, 10;110(37)15097-102 (IF 9,737)
  8. Morgen K, Frölich L, Tost H, Plichta MM, Kölsch H, Rakebrandt F, Rienhoff O, Jessen F, Peters O, Jahn H, Luckhaus C, Hüll M, Gertz HJ, Schröder J, Hampel H, Teipel SJ , Pantel J, Heuser I, Wiltfang J, Rüther E, Kornhuber J, Maier W, Meyer-Lindenberg A.. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to AD. J Alz Dis, 2013, 37(2):389-401 (IF 4,174)
  9. Blautzik J, Keeser D, Berman A, Paolini M, Kirsch V, Mueller S, Coates U, Reiser M, Teipel SJ, Meindl T. Long-Term Test-retest Reliability of Resting-State Networks in Healthy Elderly Subjects and Mild Cognitive Impairment Patients. J Alzheimers Dis., 2013, 34(3):741-54 (IF 4,174)
  10. Dyrba M , Ewers M, Wegrzyn M, Kilimann I , Plant C, Oswald A, Meindl T, Pievani M, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Hauenstein KH, Kirste T, Teipel SJ and the EDSD study group. Robust automated detection of microstructural white matter degeneration in Alzheimer’s disease using machine learning classification of multicenter DTI data. Plos One, 2013, 8(5):e64925 (IF 4,092)
  11. Grothe M , Heinsen H, Teipel SJ . Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer´s disease. Neurobiol. Aging, 2013, 34(4):1210-20 (IF 6,189)
  12. Schwarz MJ, Guillemin GJ, Teipel SJ , Bürger K, Hampel H. Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls. Eur Arch Psychiatry Clin Neurosci, 2013, 263(4):345-52 (IF 3,494)
  13. Wegrzyn M, Teipel SJ , Oltmann I, Bauer A, Thome J, Großmann A, Hauenstein KH, Höppner J. Structural and functional cortical disconnection in Alzheimer’s disease: a combined study using diffusion tensor imaging and transcranial magnetic stimulation
    Psychiatry Res. Neuroimaging, 2013, 212(3):192-200 (IF 2,964)
  14. *Teipel SJ , Sabri O, Grothe M, Barthel H, Prvulovic D, Bürger K, Bokde A, Ewers M, Hoffmann W, Hampel H. Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer’s Disease. J Alzheimers Dis. 2013, 33(0): 329-47 (IF 4,174)
  1. Sebastian Thomas Balbach, Telma Cristina Esteves, Franchesca Dawn Houghton, Siatkowski M , Pfeiffer MJ, Tsurumi Ch, Kanzler B, Fuellen G, Boiani M. Nuclear Reprogramming: Kinetics of Cell Cycle and Metabolic Progression as Determinants of Success. Plos one, 2012, 7 (4)(IF 4,902)
  2. Doblhammer, G ; Fritze, T . Demographische Einflussfaktoren auf Pflege und Demenzerkrankungen. Die BKK , 2012, 100(9): 400-403 (IF -)
  3. Prudlo J , Bißbort C, Glass A, Grossmann A, Hauenstein K, Benecke R, Teipel SJ. White matter pathology in ALS and lower motor neuron ALS variants: a diffusion tensor imaging study using tract-based spatial statistics. J Neurol., 2012 , 259(9):1848-59 (IF 3,473)
  4. Lueke S , Kehrwieder N, Hoffmann W , Teipel S, Fleßa S. Quality features of German memory clinics: a cross-sectional study. Nervenarzt, 2012, 83(9):1178-89 (IF 0,681)
  5. Likitjaroen Y, Meindl T, Friese U, Wagner M, Buerger K, Hampel H, Teipel SJ. Longitudinal changes of fractional anisotropy in Alzheimer’s disease patients treated with galantamine: a 12-month randomized, placebo-controlled, double-blinded study. Eur Arch Psychiatry Clin Neurosci., 2012; 262(4):341-50 (IF 3,494)
  6. Grothe M , Heinsen H, Teipel SJ . Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer’s disease. Biol Psychiat, 2012; 71(9):805-13 (IF 8,283)
  7. Soldner J, Meindl T, Koch W, Bokde AL, Reiser MF, Möller HJ, Bürger K, Hampel H, Teipel SJ . Structural and functional neuronal connectivity in Alzheimer’s disease: a combined DTI and fMRI study. Nervenarzt, 2012; 83(7):878-87 (IF 0,681)
  8. Likitjaroen Y, Suwanwela NC, Mitchell AJ, Lerdlum S, Phanthumchinda K, Teipel SJ . Isolated motor neglect following infarction of the posterior limb of the right internal capsule: a case study with diffusion tensor imaging-based tractography. J Neurol., 2012; 259(1):100-5 (IF 3,473)
  9. Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ , Weiner M, Hampel H; Alzheimer's Disease Neuroimaging Initiative. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer’s disease. Neurobiol Aging, 2012, 33(8):1599-608 (IF 6,189)
  10. Koch W, Teipel S , Mueller S, Benninghoff J, Wagner M, Bokde AL, Hampel H, Coates U, Reiser M, Meindl T. Diagnostic power of default mode network resting state fMRI in the detection of Alzheimer’s disease. Neurobiol Aging, 2012; 33(3):466-78 (IF 6,189)
  11. Filippi M, Agosta F, Barkhof F, Dubois B, Fox N, Frisoni G, Jack, CR, Johannsen P, Miller B, Nestor PJ, Scheltens P, Sorbi S, Teipel SJ, Thompson P, Wahlund LO. EFNS Task Force: The use of neuroimaging in the diagnosis of dementia. Eur J Neurology, 2012, 19(12): 1487-501(IF 3,692)
  12. Buschert V, Giegling I, Teipel SJ , Jolk S, Hampel H, Rujescu D, Buerger K (2012) Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment. J Clin Psychiat 2012, 73(12):e1492-8 (IF 5,799)
  13. Peters O, Lorenz D Fesche A, Schmidtke K, Hull M, Perneczky R, Ruther E, Moller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schroder J, Pantel J, Teipel SJ Wellek S, Frolich L, Heuser I. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI. J Nutr Health Aging, 2012; 16(6):544-8 (IF 2,686)
  14. Jahns KO, Kilimann I , Ritter CA, Hoffmann W , Teipel SJ, Fiss T . Medication review for dementia patients. Med Monatsschr Pharm, 2012;35(3): 95-103 (IF -)
  15. Teipel SJ, Wegrzyn M, Meindl T, Frisoni G, Bokde A, Fellgiebel A, Filippi M, Hampel HJ, Klöppel S, Hauenstein K, Ewers M. Anatomical MRI and DTI in the diagnosis of Alzheimer’s disease: a European Multicenter Study, J Alzheimers Dis 2012, 31 Suppl 3: 33-47 (IF 3,745)
  16. Höppner J, Wegrzyn M , Thome J, Bauer A, Oltmann I, Buchmann J, Teipel SJ . Intra- and inter-cortical motor excitability in Alzheimer’s Disease. J Neural Trans. 2012;119(5):605-12 (IF 2,730)
  17. Thyrian R, Fiß Th, Dreier A, Böwing G, Angelow A, Lueke S , Teipel SJ , Fleßa HJ, Freyerger HJ, Hoffmann W . Dementia: Life- and person-centered help in Mecklenburg-Western Pomerania, Germany (DelpHi) – study protocol for a cluster-randomised controlled trial. Trials 2012;13(1):56 (IF 2,496)
  18. Fischer FU, Scheurich A, Wegrzyn M, Schermuly I, Bokde A, Klöppel S, Pouwels P, Teipel SJ , Yakushev I, Fellgiebel A. Automated tractography of the cingulate bundle in Alzheimer’s Disease: a multicenter DTI Study. J Magnetic Res Imag., 2012;36(1):84-91(IF 2,698)
  19. Mueller S, Keeser D, Reiser MF, Teipel S , Meindl T. Functional and Structural MR Imaging in Neuropsychiatric Disorders, Part 2: Application in Schizophrenia and Autism. AJNR Am J Neuroradiol. 2012, 33(11): 2033-7 (IF 2,928)
  20. Mueller S, Keeser D, Reiser MF, Teipel S , Meindl T. Functional and Structural MR Imaging in Neuropsychiatric Disorders, Part 1: Imaging Techniques and Their Application in Mild Cognitive Impairment and Alzheimer Disease. AJNR Am J Neuroradiol. 2012; 33(10):1845-1850 (IF 2,928)
  21. Schmidt A, Pahnke J ,
    Efficient Near-Infrared in vivo imaging of amyloid-ß deposits in AD mouse models
    J Alzheimers Dis, 2012, 30(3): 651-64 (IF 4,26)
  22. Doblhammer, G . Kreft, D., Dethloff, A.
    Gewonnene Lebensjahre: Langfristige Trends und zukünftige Potentiale der Sterblichkeit nach Todesursachen in Deutschland und im internationalen Vergleich. Bundesgesetzblatt, 2012, in press (IF -)
  1. Hampel H, Prvulovic D, Teipel S , Jessen F, Luckhaus C, Frölich L, Riepe MW, Dodel R, Leyhe T, Bertram L,Hoffmann W, Faltraco F; for the German Task Force on AD (GTF-AD)
    The future of Alzheimer's Disease: The next 10 years. Prog Neurobiol, 2011, 95 (4): 718-28 (IF 9,97)
  2. Teipel SJ , Peters O, Heuser I, Jessen F, Maier W, Froelich L, Arlt S, Hüll M, Gertz HJ, Kornhuber J, Wiltfang J, Thome J, Rienhoff O, Meindl T, Hampel H, Grothe M.
    Atrophy outcomes in multicentre clinical trials on Alzheimer's disease: Effect of different processing and analysis approaches on sample sizes. World J Biol Psychiatry, 2011, 12 Suppl 1:109-113 (IF 2,05)
  3. Ewers M, Frisoni GB, Teipel SJ, Grinberg LT, Amaro E Jr., Heinsen H, Thompson PM, Hampel H.
    Staging Alzheimer's Disease progression with multimodality neuroimaging. Prog Neurobiol, 2011, 95 (4): 535-46 (IF 9,97)
  4. Frings L, Klöppel S, Teipel S, Peters O, Frölich L, Pantel J, Schröder J, Gertz HJ, Arlt S, Heuser I, Kornhuber J, Wiltfang J, Maier W, Jessen F, Hampel H, Hüll M.
    Left Anterior Temporal Lobe Sustains Naming in Alzheimer's Dementia and Mild Cognitive Impairment. Curr Alzheimer Res, 2011, 8, 893-901 (IF 4,97)
  5. C. G. Schipke, F. Jessen, S. Teipel , C. Luckhaus, J. Wiltfang, H. Esselmann, L. Frölich, W. Maier, E. Rüther, F. Heppner, S. Prokop, I. Heuser , O. Peters
    Long-term stability of AD biomarker proteins in cerebrospinal fluid. J Alzheimers Dis, 2011, 26 (2): 255-262 (IF 4,26)
  6. Ewers M, Cheng X, Zhong Z, Nural HF, Walsh C, Meindl T, Teipel SJ , Buerger K, He P, Shen Y, Hampel H.
    Increased CSF-BACE1 Activity Associated with Decreased Hippocampus Volume in Alzheimer's Disease. J Alzheimers Dis, 2011, 25 (2): 373-381 (IF 4,26)
  7. Schneider P, Buerger K , Teipel S , Uspenskaya O, Hartmann O, Hansson O, Minthon L, Rujescu D, Moeller HJ, Zetterberg H, Blennow K, Ernst A, Bergmann A, Hampel H.
    Antihypertensive Therapy Is Associated with Reduced Rate of Conversion to Alzheimer's Disease in Midregional Proatrial Natriuretic Peptide Stratified Subjects with Mild Cognitive Impairment. Biol Psychiatry, 2011, 70(2): 145-51 (IF 8,92)
  8. M. R Turner, J. Grosskreutz, J. Kassubek, S. Abrahams, F. Agosta, M. Benatar, M. Filippi, L. H. Goldstein, M. van den Heuvel, S. Kalra, D. Lulé, B. Mohammadi & other members of ‘The 1st NISALS’*

    *Other contributors to The 1st Neuroimaging Symposium in ALS (NISALS): N. Atassi, P. Bede, H. Benali, Chr. Enzinger, Chr. Gaser, L. Jelsone-Swain, H.-P. Müller, R. W. Orrell, P.-F. Pradat, J. Prudlo, S. Ropele, R.Sharma, V. Silani, A. Simmons, S. Smith, S. Teipel, A. Toosy, S. Tsermentseli, P. Van Damme, E. Verstraete, R. Welsh, M. Wittstock
    Towards a neuroimaging biomarker in amyotrophic lateral sclerosis
    Lancet Neurol, 2011, 10 (5): 400-403 (IF 18,1)
  9. Förster, Buschert, Buchholz, Teipel , Friese, Zach, la Fougere, Rominger, Hampel, Bartenstein and Buerger. Effects of a 6-month cognitive intervention program on brain metabolism in amnestic MCI and mild Alzheimer´s disease. J Alzheimers Dis, 2011, 25 (4): 695-706 (IF 4,26)
  10. Teipel SJ , Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein K-H, Filippi M, Ernemann U, Reiser M, Hampel H. Longitudinal changes in fibre tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis, 2011, 22 (2): 507-522 (IF 4,26)
  11. Teipel SJ , Buchert R, Thome J, Hampel H, Pahnke J .
    Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression. Prog Neurobiol, 2011, 95(4): 547-56 (IF 9,97)
  12. Teipel SJ , Meindl T, Grinberg L, Grothe M, Cantero JL, Reiser MF, Möller H-J, Heinsen H, Hampel H. The cholinergic system in mild cognitive impairment and Alzheimer’s disease: an in vivo MRI and DTI study. Hum Brain Mapp, 2011, 32 (9): 1349-1362 (IF 6,25)
  13. Buschert VC, Friese U, Teipel SJ , Schneider P, Merensky W, Rujescu D, Möller HJ, Hampel H, Buerger K. Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer’s disease: a pilot study. J Alzheimers Dis, 2011, 25 (4): 679-694 (IF 4,26)
  14. Markus Krohn, Cathleen Lange, Jacqueline Hofrichter, Katja Scheffler, Jan Stenzel, Johannes Steffen, Toni Schumacher, Thomas Brüning, Anne-Sophie Plath , Franziska Alfen, Anke Schmidt , Felix Winter, Katja Rateitschak, Andreas Wree, Jörg Gsponer, Lary C. Walker, and Jens Pahnke. Cerebral amyloid-® proteostasis is regulated by the membrane transport protein ABCC1 in mice. J Clinical Investigation, 2011, (IF 14,15)
  15. Teipel, S . J., Kaza, E., Hadlich, S., Bauer, A., Bruning, T., Plath, A-S. , Krohn, M., Scheffler, K., Walker, L. C., Lotze, M. and Pahnke, J . Automated detection of amyloid-beta-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI. J Alzheimers Dis, 2011, 23 (2): 221-237 (IF 4,26)
  16. Klöppel S, Abdulkadir A, Hadjidemetriou S, Issleib S, Frings L, Thanh TN, Mader I, Teipel SJ , Hüll M, Ronneberger O. A comparison of different automated methods for the detection of white matter lesions in MRI data. Neuroimage, 2011, 57 (2): 416-22 (IF 5,74)
  17. Teipel SJ, Reuter S, Stieltjes B, Acosta-Cabronero J, Ernemann U, Fellgiebel A, Filippi M, Frisoni G, Hentschel F, Jessen F, Klöppel S, Meindl T, Pouwels PJ, Hauenstein KH, Hampel H. Multicenter stability of diffusion tensor imaging measures: A European clinical and physical phantom study. Psych Res, 2011, 194 (3): 363-71(IF 3,4)
  18. Bach, J.-P., Ziegler, U., Deuschl, G., Dodel, R., Doblhammer-Reiter, G .
    Projected numbers of people with movement disorders in the years 2030 and 2050.
    Movement Dis, 2011, Vol 26, Issue 12, 2286-290 (IF -)
  19. Doblhammer, G ., Kreft, D.
    Länger leben, länger leiden? Trends in der Lebenserwartung und Gesundheit.
    Bundesgesblatt, 2011, 54:907-914, DOI: 10.1007/s00103-011-1315-0 (IF -)
  20. Scheffler K, Stenzel J, Krohn M, Lange C, Hofrichter J, Schumacher T, Brüning T, Plath A , Walker LC, Pahnke J
    Determination of spatial and temporal distribution of microglia by 230nm high-resolution, high-throughput automated analysis reveals different amyloid plaque populations in an APP/PS1 mouse model of Alzheimer’s disease. Current Alzheimer Research, 2011, 8(7): 781-8 (IF 4,97)
  21. Schmidt A , Eipel C, Fürst K, Sommer N, Pahnke J , and Pützer BM
    Evaluation of systemic targeting of RET oncogene-based aggressive MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models. Hum Gene Therapy, 2011, 18, 418-423 (IF 4,8)
  22. Pfeiffer MJ, Siatkowski M , Paudel Y, Balbach ST, Baeumer N, Crosetto N, Drexler HC, Fuellen G , Boiani M.
    Proteomic Analysis of Mouse Oocytes Reveals 28 Candidate Factors of the "Reprogrammome". J Proteome Res, 2011, 10(5): 2140-53 (IF 5,13)
  1. Teipel SJ , Ewers M, Wolf S, Jessen F, Kolsch H, Arlt S, Luckhaus C, Schonknecht P, Schmidtke K, Heuser I, Frolich L, Ende G, Pantel J, Wiltfang J, Rakebrandt F, Peters O,Born C, Kornhuber J, Hampel H. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res, 2010, 182: 244-250 (IF 2,37)
  2. Luckhaus C, Jänner M, Cohnen M, Flüss MO, Teipel SJ , Grothe M, Hampel H, Kornhuber J, Rüther E, Peters O, Supprian T, Gaebel W, Mödder U, Wittsack HJ. A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables. Eur J Neurol. 2010, 17(12):1437-44 (IF 3,76)
  3. Grothe M, Zaborszky L, Atienza M, Gil-Neciga E, Rodriguez-Romero R, Teipel SJ , Amunts K, Suarez-Gonzalez A, Cantero JL. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease. Cereb Cortex. 2010, 20(7):1685-95 (IF 6,84)
  4. Hampel H, Frank R, Broich K, Teipel SJ , Katz RG, Hardy J, Herholz K, Bokde AL, Jessen F, Hoessler YC, Sanhai WR, Zetterberg H, Woodcock J, Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat Rev Drug Discov, 2010, 9: 560-574 (IF 29,05)
  5. Luckhaus C, Cohnen M, Fluss MO, Janner M, Grass-Kapanke B, Teipel SJ , Grothe M, Hampel H, Peters O, Kornhuber J, Maier W, Supprian T, Gaebel W, Modder U, Wittsack HJ
    The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia. Psychiatry Res, 2010, 183, 44-51 (IF 2,37)
  6. Friese U, Meindl T, Herpertz SC, Reiser MF, Hampel H, Teipel SJ . Diagnostic Utility of Novel MRI-Based Biomarkers for Alzheimer's Disease: Diffusion Tensor Imaging and Deformation-Based Morphometry. J Alzheimers Dis, 2010, 20 (2):477-490 (IF 3,83)
  7. Teipel SJ , Bokde A. L., Meindl T, Amaro jr. E, Reiser MF, Herpertz S, Möller HJ, Hampel H.
    White matter microstructure underlying default mode network connectivity in the human brain
    Neuroimage, 2010, 49( 3):2021-32 (IF 5,73)
  8. Plant C, Teipel SJ , Oswald A, Böhm C, Meindl T, Mourao-Mirandaf J, Bokde ALW, Hampel H, Ewers M. Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer’s disease. Neuroimage, 2010, 50 (1): 162-174 (IF 5,73)
  9. Bergfield KL, Hanson KD, Chen K, Teipel SJ , Hampel H, Rapoport SI, et al.
    Age-related networks of regional covariance in MRI grey matter: reproducible multivariate patterns in healthy aging. Neuroimage, 2010, 49 (2): 1750-59 (IF 5,73)
  10. Gregor Warsow, Boris Greber, Steffi SI Falk, Clemens Harder, Marcin Siatkowski , Sandra Schordan, Anup Som, Nicole Endlich, Hans Schöler, Dirk Repsilber, Karlhans Endlich, Georg Fuellen
    ExprEssence - Revealing the essence of differential experimental data in the context of an interaction/regulation net-work. BMC Systems Biology, 2010, (IF 4,06)
  11. Anup Som, Clemens Harder, Boris Greber, Marcin Siatkowski , Yogesh Paudel, Gregor Warsow, Clemens Cap, Hans Schöler, Georg Fuellen
    The PluriNetWork: An Electronic Representation of the Network Underlying Pluripotency in Mouse, and Its Applications. Plos One, 2010, 5 (12): e 15165 (IF 4,35)

Buchkapitel

  1. Handbuch Alzheimer-Krankheit, Grundlagen-Diagnostik-Therapie-Versorgung-Prävention, Jessen F. (Hrsg.), Kapitel 6: Diagnostische Methoden, 6.4 Bildgebende Diagnostik - Magnetresonanztomographie; Kilimann I, Grothe M, Teipel SJ; De Gruyter Verlag, 2018, Seite 230 - 248
  2. Grothe M , Kurth J, Hampel H, Krause B, Teipel S . Standardization of MRI and Amyloid Imaging, in: Bairu M, Weiner M (Eds.), Global Clinical Trials for Alzheimer's Disease: Design, Implementation, and Standardization. Academic Press (Elsevier) 2016, pp. 131-156
  3. Grothe MJ , Bokde ALW, Teipel SJ. Functional and Structural MRI in Alzheimer’s Disease: A Multimodal Approach, in: Mulert C, Shenton ME (Eds.), MRI in Psychiatry. Springer Berlin Heidelberg 2014 (in press)
  4. Gedächtnisstörungen, Diagnostik und Rehabilitation, Bartsch T, Falkai P (Hrsg.), Kapitel 18: Alzheimer Krankheit; Kilimann I, Teipel SJ, Springer Verlag, 2014, Seite 239-262
  5. Systemische Neurowissenschaften in der Psychiatrie, Gruber O, Falkai P (Hrsg.), Kapitel: Deformationsbasierte Morphometrie und Diffusion Tensor Imaging; Teipel SJ , Hampel H; Kohlhammer-Verlag, 2013, Seite 52-72
  6. Alzheimer’s disease – Modernizing Concept, Biological Diagnosis and Therapy, Hampel H, Carrillo MC (editors), Chapter: MRI- and PET-Based Imaging Markers for the Diagnosis of Alzheimer’s Disease. Teipel S , Sperling RA, Skudlarski P, Jack C, Hampel H, Fellgiebel A, Herholz K, Karger Verlag 2012, Vol 28, Seite 80-114
  7. Handbook of Imaging The Alzheimer Brain,
    Editors: J.W. Ashford, A. Rosen, M. Adamson, P. Bayley, O. Sabri, A. Furst, S.E. Black
    and M. Weiner
    Section 4: Current Advances in Functional Magnetic Resonance Imaging for Detecting AD
    Verbal Working Memory in Amnestic Mild cognitive Impaired Subjects: an fMRI study
    Bokde, Karmann, Born, Teipel , Omerovic, Ewers, Frodl, Meisenzahl, Reiser, Möller and Hampel, IOS Press, 2011
  8. Handbook of Imaging The Alzheimer Brain,
    Editors: J.W. Ashford, A. Rosen, M. Adamson, P. Bayley, O. Sabri, A. Furst, S.E. Black and M. Weiner
    Section 6: Diffusion Tensor Imaging
    Detection of Alzheimer’s Disease with Diffusion Tensor Imaging and Deformation-based Morphometry
    Friese, Meindl, Herpertz, Reiser, Hampel and Teipel , IOS Press, 2011
  9. Handbook of Imaging The Alzheimer Brain,
    Editors: J.W. Ashford, A. Rosen, M. Adamson, P. Bayley, O. Sabri, A. Furst, S.E. Black and M. Weiner
    Section 6: Diffusion Tensor Imaging
    White Matter Microstructure in Relation to Education in Aging and Alzheimer’s Disease
    Teipel , Meindl, Wagner, Kohl, Bürger, Reiser, Herpertz, Möller and Hampel, IOS Press, 2011

Bücher

  1. Doblhammer, G., Schulz, A., Steinberg, J. and Ziegler, U. Demografie der Demenz. Bern, Verlag Hans Huber, Hofgrefe AG, 2012

Andere Publikationen

  1. Teipel SJ. Risk and resilience: A new perspective on Alzheimer’s disease, Geriatric Mental Health Care, Vol 1, Issue 3, 2013, 47-55
  2. Koldrack P, Luplow M, Kirste Th, Teipel SJ. Cognitive Assistance to support social integration in Alzheimer’s disease, Geriatric Mental Health Care, Vol 1, Issue 2, 2013, 39-45
  3. Doblhammer G, Fink A, Fritze Th, Günster C, The demography and epidemiology of dementia, Geriatric Mental Health Care, Vol 1, Issue 2, 2013, 29-33
  4. Kurth J, Sakretz M, Teipel SJ, Krause BJ, Molecular imaging of dementia; Geriatric Mental Health Care, Vol 1, Issue 3, 2013, 56-62
  5. Teipel SJ, Cognitive Ageing – chance and challenge, Geriatric Mental Health Care, Vol 1, Issue 2, 2013, 27-28
  6. Schwarz S, Demenz: Krankheit akzeptieren,Heilberufe, Ausgabe 9, 2012